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ABSTRACT
Competing risks data are commonly encountered in biomedical studies when sub-
jects are subject to failure from many distinct causes. In this dissertation, we propose
new methods for analyzing clustered competing risks data (Chapters 1 and 2) and
for instrumental variable analysis of censored time-to-event data (Chapters 3 and 4).
In Chapter 1, we consider the problem of evaluation of center performance on mul-
tiple competing events. We propose estimating center effects through cause-specific
proportional hazards frailty models that allow correlation among a centers cause-
specific effects. Estimation of our model proceeds via penalized partial likelihood
and is implemented in R. To evaluate center performance, we also propose a directly
standardized excess cumulative incidence (ECI) measure. Therefore, based on our
proposed methods, practitioners can evaluate centers either through the cause-specific
hazards or the cumulative incidence functions. We demonstrate, through simulations,
the advantages of the proposed methods to detect outlying centers, by comparing the
proposed methods and existing methods which assume uncorrelated random center
effects. In addition, we develop a Correlation Score Test to test the null hypothesis
that the competing event processes within a center are uncorrelated. Using data from
the Scientific Registry of Transplant Recipients, we apply our method to evaluate the
performance of Organ Procurement Organizations on two competing risks: (i) receipt
of a kidney transplant and (ii) death on the wait-list.
In Chapter 2, we propose to model the effects of cluster and individual-level co-
variates directly on the cumulative incidence functions of each risk through semipara-
metric additive regression models containing cluster-specific random effects. A unique
x
feature of our approach is that we model the dependency of failure times both within
and across causes among individuals within a cluster by allowing for the correlation
of cluster-specific random effects across causes. By decomposing the cause-specific
cumulative incidence functions using a mixture model representation, we are able to
estimate model parameters associated with all competing risks under consideration,
satisfying the constraint that the sum of cumulative incidence functions does not ex-
ceed one. We develop estimating equations for parameter estimation and test our
estimation procedure via simulations. We apply our method to multicenter compet-
ing risks data from the Scientific Registry of Transplant Recipients.
In Chapter 3, we turn our focus to causal inference in the censored time-to-event
setting in the presence of unmeasured confounders. Unmeasured confounding of the
relationship between a treatment and outcome of interest is a major concern in any
observational study. Instrumental variable (IV) analysis methods are able to control
for unmeasured confounding. However, IV analysis methods developed for censored
time-to-event data tend to rely on assumptions that may not be reasonable in many
practical applications, making them unsuitable for use in observational studies. In
this chapter, we develop weighted estimators of the complier average causal effect on
the restricted mean survival time. Our method is able to accommodate instrument-
outcome confounding and adjust for covariate dependent censoring, making it partic-
ularly suited for causal inference from observational studies. We establish the asymp-
totic properties and derive easily implementable asymptotic variance estimators for
the proposed estimators. Through simulation studies, we show that the proposed
estimators tend to be more efficient than propensity score matching based estimators
or inverse probability of treatment weighted estimators in certain situations, and tend
to perform as well in other situations. We apply our method to compare HD and PD
modalities for end stage renal disease (ESRD) patients using data from the United
States Renal Data System (USRDS).
xi
In Chapter 4, we develop an instrumental variable analysis method for competing
risks data. Very few methods have been developed to address the problem of unmea-
sured confounding in the competing risks setting. Further, existing methods focus
on estimating causal effects on a single, primary cause of interest. In doing so, these
methods tend to overlook important features of the exposure-outcome relationship
and ignore the interplay between causes. We develop a method that permits simul-
taneous inference of causal effects on the absolute risk or cumulative incidence of all
causes. By using a semiparametric mixture component model, we ensure that the
additivity constraint for the cause-specific cumulative incidence functions is satisfied.
Our method makes no restriction about the type of exposure or IV and is able to ac-
commodate exposure dependent censoring. We demonstrate finite sample properties
through simulation studies. Using data from the United States Renal Data System
(USRDS), we apply our method to compare HD and PD modalities for end stage
renal disease (ESRD) patients with respect to two competing outcomes: (i) risk of
death from cardiovascular diseases and (ii) risk of death from other causes.
xii
CHAPTER I
Evaluating center performance in the competing
risks setting: Application to outcomes of
wait-listed end-stage renal disease patients
1.1 Introduction
The availability of electronic health records and the demand for value-driven
healthcare have led to greatly increased interest in the methods for evaluation of
center performance (Ash et al., 2012). For continuous or binary outcomes, center
effects are usually estimated as either fixed or random effects models. Evaluation of
center performance is then generally carried out by comparing these estimated risk-
adjusted center effects to some fixed quantity, or the average center effect, or by using
graphical checks (Spiegelhalter et al., 2012).
The proposed methods are motivated by the end-stage renal disease (ESRD) set-
ting. There are thousands more patients in need of transplantation than there are
donor kidneys. As a result medically suitable ESRD patients are placed on a wait-
ing list. For example, in 2015, there were 98,956 patients on the kidney waiting list
at year-end, but only 11,594 deceased-donor kidney transplants (Hart et al., 2016).
In the United States, there are 58 wait-lists, each administered by an Organ Pro-
curement Organization (OPO). Our objective here is to evaluate OPOs with respect
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to (i) kidney transplantation and (ii) pre-transplant death (competing risks) among
wait-listed patients.
While there has been extensive research conducted into establishing methods for
institutional comparisons with respect to binary and continuous outcomes, apart from
a few recent studies, time-to-event outcomes have received considerably less attention.
He and Schaubel (2014a) assessed the standardized mortality ratio (SMR) measure
based on the Cox model and developed an alternative based on stratification. In
another study, He and Schaubel (2014b) developed a direct standardized measure of
center performance.
Oftentimes in clinical and epidemiological settings, there is more than one com-
peting outcome of interest. In such cases, there are two approaches to conceptualize
the event times for the competing risks. The first approach assumes that, for every
patient, a latent event time (Gail, 1975; Crowder, 2001) exists for each outcome and
only the minimum of these (Cox, 1959) is observed. Under this conceptualization, la-
tent event times must act independently in order for marginal quantities (e.g., cause-
or event-specific survival function) to be identifiable. A second approach, adopted
by us, assumes that only one event time, pertaining to the cause of failure, exists
for each subject (Kalbfleisch and Prentice, 2002). Data from such settings can now
be analyzed through the analysis of cause-specific hazards (Kalbfleisch and Prentice,
2002; ?).
With competing risks data, a comparison of centers with respect to all-cause mor-
tality has the potential to obscure important findings by averaging of dissimilar results
(Van Rompaye et al., 2010). An analysis by cause has the potential to yield more in-
terpretable and insightful conclusions (Putter et al., 2007). Fan and Schaubel (2016)
proposed, as a center performance measure, the difference between the estimated cu-
mulative incidence of transplant for patients at a given center and the average of the
estimated cumulative incidences. Based on similar techniques, Van Rompaye, Erik-
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son and Goetghebeur (2015) developed an ‘excess cause-specific cumulative incidence’
(ECI). For indirectly standardized measures, center performance is evaluated at the
patient mix or covariate distribution of each center. Although useful for internal
benchmarking, directly standardized measures are preferred for comparisons across
centers (Varewyck et al., 2014). Note that random center effects may be preferable
to fixed effects in the presence of small center sizes (Ash et al., 2012; Ohlssen et al.,
2006; Kalbfleisch and Wolfe, 2013).
Most existing methods for clustered competing risks model the within-cluster
dependence through a random effect, and concentrate on a single risk (or separate
models for each risk) (Katsahian and Boudreau, 2011; Do Ha et al., 2014). In contrast,
we propose a class of frailty models which allow a centers cause-specific random effects
be correlated. This approach utilizes the additional information available in the form
of correlation between cause-specific random effects within a center.
In this chapter, we develop a directly standardized ECI measure to contrast center
performance on competing outcomes. We utilize an easily implementable penalized
partial likelihood method (Ripatti and Palmgreen, 2000). Note that Gorfine and
Hsu (2011) and Gorfine et al. (2014) also developed frailty models for correlated
event times within-cluster. However, an Expectation-Maximization (EM) algorithm
was used which requires numerical integration at each E-step. In comparison, our
estimation procedure does not require any numerical integration and is implemented
through a single call to coxme function of the coxme package (Therneau, 2009).
If competing events are indeed uncorrelated, fitting separate models is appropriate
and easier than the proposed methods. Therefore, we also develop a convenient score
test for the presence of correlation between competing risks within-center. The score
test does not require fitting the joint model and, thus, provides an a priori checks
the appropriateness of using separate cause-specific models, in lieu of the proposed
methods.
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1.2 Proposed Methods
1.2.1 Model and Likelihood
There are J centers or clusters, with each center j having nj members (j =
1, . . . , J) so that there are
∑J
j=1 nj = n individuals in the entire sample. For each
subject i(i = 1, ..., nj) in center j, let T
0
ij and Cij denote the failure time and the
censoring time, respectively, and let Xij be a vector of time-independent covariates.
The observed event time is then defined as Tij = min (T
0
ij, Cij). Each subject fails
due to one of K causes, we use ∆ij (∆ij ∈ {0, ..., K}) to indicate the cause of the
observed failure for subject i in center j, with ∆ij = 0 if T
0
ij > Cij. The observed
data consist of {Tij,∆ij,Xij, Aij} for i = 1, . . . , nj and (j = 1, . . . , J), where Aij = 1
if subject i belongs to center j and 0 otherwise.
Additionally, we define a vector of center-specific random effects or frailties, for the
jth center, γj = (γj1, ..., γjK)
T , given which the event times for all subjects within
that center are assumed to be conditionally independent. Thus, the cause-specific
hazard function for cause k, for the subject i in the center j, is given by:
λijk(t|Xij, γjk) = lim
h↓0
1
h
Pr(t ≤ T 0ij < t+ h,∆ij = k|T 0ij ≥ t,Xij, γjk)
and is assumed to be following the proportional hazards model:
λijk(t|Xij, γjk) = λ0k(t) exp{βTkXij + γjk} (1.1)
for k = 1, .., K where β1, ...,βk and λ01, ...λ0k are cause-specific regression coefficients
and cause-specific baseline hazards respectively. Here, we assume that the vector of
covariates Xij is the same for all causes, but it can be replaced by cause-specific
vectors of covariates Xijk. The center-specific random effects imply a correlation
between the cause-specific hazards across subjects within a center. Further, by as-
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suming that the center-specific random effect vectors arise from a multivariate normal
distribution with mean zero and covariance matrix Vj, i.e., γj ∼ MVN(0,Vj), our
model allows for the association of different cause-specific hazards across individuals
within a center. It is important to note that our model implies that the cause-specific
hazards for different causes may be correlated across individuals within a center and
not that the cause-specific event times within each individual are correlated. Indeed,
as we do not adopt the latent failure time paradigm, our model is agnostic about the
existence of different cause-specific event times within each individual.
We focus on the case of K = 2 competing causes, and allow for center-specific ran-
dom effects for the two different causes to be negatively associated, i.e., Corr(γj1, γj2) ≤
0. To this end we reformulate the cause-specific hazards in equation (1.1) as
λij1(t|Xij, b0j , b1j) = λ01(t) exp{βT1Xij + b1j + b0j} (1.2)
λij2(t|Xij, b0j , b2j) = λ02(t) exp{βT1Xij + b2j − b0j} (1.3)
where b1j + b
0
j = γj1 and b
2
j − b0j = γj2. We have decomposed a center’s cause-specific
random-effect into two independent components: a shared random-effect, b0j , acting
in opposite directions on the hazards of the two different risks, and a cause-specific
random effect component bkj . This implies that Cov(γj1, γj2) = −Var(b0j). We further
assume that jointly bj = (b
0
j , b
1
j , b
2
j) ∼ p(bj;Dj) = MVN(0,Dj(θj)), where Dj(θj) is
a diagonal covariance matrix with unknown parameters denoted by the vector θj.
We now construct the likelihood function for the model implied in equation (1.1) in
terms of the parameters (λ0(t),β
T
k ,θj). Note that, for any given subject, λij(t|Xij, bj) =∑K
k=1 λijk(t|Xij, bj). Thus, the cause-specific densities can be represented as fijk(t|Xij, bj) =
λijk(t|Xij, bj)Sij(t|Xij, bj) for k = {1, .., K}, where Sij(t|Xij, bj) = exp{−
∑K
k=1 λijk(t|Xij, bj)}.
Hence, the likelihood function can be written in terms of cause-specific hazard func-
tions. Let the at-risk indicator for subject i in center j be given by Yij(t) = I(Tij ≥ t).
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Using the notation given in Section 1.2.1, we write the likelihood for subjects in center
j as:
Lj =
∫ nj∏
i=1
K∏
k=1
{
λ0k(Tij) exp{βTkXij + bTj Zijk}
}I(∆ij=k)
×
exp(− t∫
0
Yij(u)λ0k(u) exp{βTkXij + bTj Zijk}du)
 p(bj;Dj(θj))dbj (1.4)
where the integral sign represents the unobserved frailties given by bj being integrated
out and Zijk are design vectors setup to obtain the cause-specific hazard models in
equations (1.2) and (1.3). Specifically, if subject i is in center j then Zij1 = (1, 1, 0)
and Zij2 = (−1, 0, 1), and if subject i does not belong to center j then Zij1 = Zij2 =
(0, 0, 0). It is important to note that for the construction of the above likelihood,
we assumed the following: (1) Conditional on {Xij,Zijk, bj}, the event times and
censoring times are independent and the censoring times are non-informative for
{βk, λ0k, k = 1, 2}, (2) Xij and bj are independent.
1.2.2 Estimation
It follows from equation (1.4) above that the overall likelihood of the data is given
by:
L =
∫ J∏
j=1
nj∏
i=1
K∏
k=1
{λ0k(Tij) exp{βTkXij + bTj Zijk}}I(∆ij=k)
× [exp(−Λ0k(Tij) exp{βTkXij + bTj Zijk})]× p(bj;Dj(θj))dbj, (1.5)
where Λ0k(Tij) exp{βTkXij + bTj Zijk} =
∫ Tij
0
Yij(u)λ0k(u) exp{βTkXij + bTj Zijk}du.
Let b = {b1T , ..., bJT}T be a vector of all random-effects, obtained by stacking
the center-specific vectors of random effects bj, j = 1, ..., J . Correspondingly, we
define p(b;D(θ)) = MVN(0,D(θ)) such that D(θ) is a block-diagonal covariance
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matrix composed of blocks formed by Dj(θj). We further assume that θj = θj′ =
(θ0, θ1, θ2); i.e., the center-specific random effect vectors, bj are i.i.d with Var(b
l
j) =
θl, l = {0, 1, 2}.
The integrand in equation (1.5) above can be viewed as the full likelihood of
the data under our model, composed of the conditional likelihood of the data given
random effects b, multiplied by the likelihood of the random effects. Taking the log,
we define:
lfull = lcond + lb =
J∑
j=1
nj∑
i=1
K∑
k=1
I(∆ij = k){log(λ0k(Tij)) + βTkXij + bjTZijk}−
J∑
j=1
nj∑
i=1
K∑
k=1
Λ0k(Tij) + β
T
kXij + bj
TZijk + log |D|− 12 − 1
2
bTD−1b (1.6)
The above equation is a penalized log-likelihood for the observed data. As in Ripatti
and Palmgren (2000), treating b as a fixed effect and using profile likelihood to esti-
mate Λ0k(t) parameters, then plugging back the resulting Breslow (1974) estimator
Λˆ0k(t) into equation (1.6) yields the following penalized partial log-likelihood (PPLL):
lppll = l1 + lb =
J∑
j=1
nj∑
i=1
K∑
k=1
I(∆ij = k){βTkXij + bjTZijk−
log
J∑
r=1
nj∑
q=1
Yqr(Tij) exp{βTkXqr + brTZqrk}}+ log |D|−
1
2 − 1
2
bTD−1b. (1.7)
As recommended in Ripatti and Palmgren (2000), we suggest obtaining the estimates
of ((βk, b), k = {1, 2}) as solutions to the PPLL. To estimate θ we need to integrate
out b. As in Breslow and Clayton (1993), we use a Laplace saddle point approximation
to the integration of penalized partial likelihood LPPLL = exp(lppll), with respect to
db. Doing so, we obtain an expression for the log of the integrated likelihood as:
lINT = −1
2
log |D| − 1
2
log |K”(bˆ)| −K(bˆ)
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K(bˆ) =
J∑
j=1
nj∑
i=1
K∑
k=1
I(∆ij = k){βTkXij+bˆTj Zijk−log
J∑
r=1
nj∑
q=1
Yqr(Tij) exp{βTkXqr+bˆTr Zqrk}}
+ log |D|− 12 − 1
2
bˆTD−1bˆ
and bˆ denotes the solution to the partial derivatives of K(b) with respect to b, i.e., bˆ
solves:
K ′(b) =
J∑
j=1
nj∑
i=1
K∑
k=1
I(∆ij = k)
[
Zijk−
∑J
r=1
∑nj
q=1 Yqr(Tij)Zqrk exp{βkXqr + brTZqrk}∑J
r=1
∑nj
q=1 Yqr(Tij)exp{βkXqr + brTZqrk}
]
−D−1b = 0.
(1.8)
The quantity K”(bˆ) is the set of second partial derivatives of K(b) at bˆ. K”(bˆ) is also
the second partial derivative of lPPLL, evaluated at bˆ. If we define H as the matrix
of second derivatives or Hessian of the PPLL with respect to (β, b), such that:
H =
H11 H12
H21 H22
 = −I(β, b) +
0 0
0 D−1

where I(β, b) = −∂2l1/∂(β, b)∂(β, b)′ , then H(β, bˆ)22 = K”(bˆ). We then have:
lINT ≈ l1(β, bˆ) + lb(θ, bˆ)− 1
2
log |H(β, bˆ)22| (1.9)
As demonstrated by Ripatti and Palmgren (2000), ignoring the last term on the
right hand side of equation (1.9) while estimating (β, b) leads to very little loss of
information. This corresponds to using the PPLL to estimate (β, b) via a Newton-
Raphson algorithm. We have the following estimating equation for β:
∂lPPLL/∂β =
8
J∑
j=1
nj∑
i=1
K∑
k=1
I(∆ij = k)
[
Xij −
∑J
j=1
∑nj
q=1 Yqr(Tij)Xqr exp{βkXqr + brTZqrk}∑J
j=1
∑nj
q=1 Yqr(Tij) exp{βkXqr + brTZqrk}
]
= 0
(1.10)
The estimating equation for b is similarly obtained by setting ∂lPPLL/∂b to zero,
and is identical to equation (1.8). Thus, equation (1.8), required for the saddle point
Laplace approximation, is automatically satisfied when PPLL is used to estimate b.
To estimate D(θ) we plug the estimated values (βˆ) into equation (1.9) and solve for
θ that maximizes lINT . This gives us the following estimating equation:
−1
2
[
tr(D−1
∂D
∂θ
) + tr(H−122
∂D−1
∂θ
)− bˆTD−1∂D
∂θ
D−1bˆ
]
= 0 (1.11)
For a diagonal covariance matrix, as in our case, we obtain the following solution:
θˆl =
(bˆl)T (bˆl) + tr(H l22(bˆ
l)
−1
)
J
, l = {0, 1, 2} (1.12)
where bˆl = {bˆl1, ...., bˆlJ} and H l22(bˆl) is the sub-matrix corresponding to bˆl terms.
The proposed estimation algorithm begins with an initial guess of θ, then alternates
between using the PPLL to estimate (β, b) as listed above and using equation (1.12)
to update θ until convergence. As suggested by Gray (1992), the variance of (βˆT , bˆT )T
is obtained as:
Vˆ (βˆ, bˆ) = H(βˆ, bˆ)−1I(βˆ, bˆ)H(βˆ, bˆ)−1 (1.13)
To obtain the asymptotic distribution for (βˆ, bˆ, λˆ0k(s)), we assumed that the in-
crements λˆ0k(s) are independent of (βˆ, bˆ). Under this assumption we estimated the
variance of λˆ0k(s) via a non-parametric bootstrap approach where the values of (βˆ, bˆ)
were treated as fixed by setting Xβˆ + bˆ as an offset in the linear predictor of the
instantaneous hazard. Thus, our desired asymptotic variance-covariance matrix for
(βˆ, bˆ, λˆ0k(s)) was obtained using equation (1.13) to estimate the variance of (βˆ, bˆ)
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and a non-parametric bootstrap approach to estimate the variance of λˆ0k(s). In do-
ing so we assume independence between λˆ0k(s) and (βˆ, bˆ). Our simulation studies
suggest this to be a safe assumption. In reality, the increments of λˆ0k(s) and (βˆ, bˆ)
may be weakly correlated. However, with increasing sample size one would expect
this correlation to get weaker and have a negligible impact on the standard errors of
estimates. Then, ignoring this correlation in return for substantial gains in compu-
tational efficiency seems appropriate. It should also be noted that, while using the
Laplace approximation to the marginal log-likelihood leads to little loss of informa-
tion, it might result in a slight underestimation of standard errors of fixed and random
effect parameters if the cluster sizes are very small, as demonstrated in Ripatti and
Palmgren (2000).
1.2.3 Center Effect Measures: Cumulative Incidence
We define the cumulative incidence function (CIF) of cause k for subject i at
center j as:
Fijk(t) = P (T
0
i ≤ t,∆i = k|Ai = j,Xij), (1.14)
the probability that an individual i in center j experiences a cause k event by time t.
To evaluate the performance of center j with respect to type k events, we first define
the average risk of events of type k at that center as Fjk(t) = EX [Fijk(t)], which is
estimated as:
Fˆjk(t) = EˆX [Fijk(t)] =
∑nj
i=1 Fijk(t)
nj
(1.15)
Note that the above equation can be interpreted as potential risk for event k, at
time t, that would be observed if the entire study population was treated at center
j, assuming there are no unmeasured confounders. To compare the performance of
center j to that of other centers we difference this potential risk with the average of
such potential risks across all the centers. We call this measure the excess cumulative
10
incidence. This is denoted as δjk(t) = Fjk(t)− EA[Fjk(t)] and estimated as:
δˆjk(t) = Fˆjk(t)−
∑J
q=1 Fˆqk(t)
J
(1.16)
1.2.4 Estimating Center Effects
We estimate cumulative incidence functions, defined in equation (1.14) using the
cause-specific hazards estimated from section 1.2. We note that the cause-specific
CIF for cause k, individual i at center j can be written as:
Fijk(t) =
t∫
0
Sij(s)λijk(s)ds, (1.17)
for which an estimate Fˆijk(t) is then obtained by plugging into equation (1.17) the
following estimated quantities:
λˆijk(s) = λˆ0k(s) exp(βˆkXij+bˆjZijk) ; Sˆij(s) = exp{−
2∑
k=1
Λˆ0k(s) exp(βˆkXij + bˆjZijk)}
where βˆk, bˆj are estimates obtained as detailed in Section 1.2.2, and Λˆ0k(t) =∫ t
0
λˆ0k(s)ds is the cumulative cause-specific baseline hazard function obtained by in-
tegrating the Breslow-Aalen (Breslow 1974) estimate of the cause-specific baseline
hazard function. Estimates of Fjk(t) and the excess cumulative incidence at center j,
δˆjk(t), are subsequently obtained by plugging Fˆijk(t) into equations (1.14) and (1.16)
respectively.
To obtain the variance of the cause-specific cumulative incidence and excess cumu-
lative incidence functions, we apply a parametric bootstrap approach. Specifically, we
re-sample the estimated parameters βˆk, bˆj and λˆ0k(s) from their estimated asymptotic
distributions to obtain bootstrapped estimates of the cumulative incidence functions.
The variance of Fˆjk(t) and δˆjk(t) are estimated as variance of the corresponding boot-
11
strapped estimates.
1.3 Score test of Correlation of Cause-specific Hazards
As mentioned in Section 1.2.1, equation (1.1), the cause-specific hazard function
for cause k, for the ith subject in center j, is assumed to follow:
λijk(t|Xi, γjk) = λ0k(t) exp{βTkXi + γjk}
Thus, the likelihood for the observed data in center j is:
Lj =
∫ nj∏
i=1
K∏
k=1
{λ0k(ti) exp{βTkXi + γjk}}∆ik(t)
×
exp(− τ∫
0
Yi(u)λ0k(u) exp{βTkXi + γjk}dt)
 p(γj;V (θ))dγj (1.18)
To develop a score test of the correlation of cause-specific hazards within centers, we
consider a special case of the model in equation (1.1) when only K = 2 causes are
present. Assume that the center-specific random effects or frailty for cause 2 and
cause 1 differ by a multiplicative constant, i.e., γj2 = ωγj1, implying the following
specification for the cause-specific hazards:
λij1(t|Xi) = λ01(t) exp{βT1Xi + γj1}; λij2(t|Xi) = λ02(t) exp{βT1Xi + ωγj1}
(1.19)
The presence of a correlation between the cause-specific hazards within centers is
then assessed by testing H0 : ω = 0. When ω = 0, there is little evidence for a linear
relationship between center-specific random effects for causes 1 and 2. Conversely,
even if the center-specific random effects are not perfectly correlated as implied by
the specification in (19) but have a dependence of the form specified in model (1) we
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would expect to reject the test of H0 : ω = 0 in favor of Ha : ω 6= 0. This is because,
in case of any non-zero correlation between the center-specific random effects, the
specification in (19) with some ω 6= 0 should provide a better fit to the observed
data than that with ω = 0. Thus, we propose to test for the presence of correlation
between cause-sepcific hazards in model (1), i.e., H0 : Cov(γj1, γj2) = 0, using the
specification in (19) and testing H0 : ω = 0.
Under the joint model for the cause-specific hazards in (19), likelihood for observed
data in center j is given by:
Lj =
∫ nj∏
i=1
{λ01(ti) exp{βT1Xi + γj1}}∆i1(t){λ02(ti) exp{βT2Xi + ωγj1}}∆i2(t)
×[exp(−
τ∫
0
Yi(u)λ01(u) exp{βT1Xi+γj1}du)][exp(−
τ∫
0
Yi(u)λ02(u) exp{βT2Xi+ωγj1}du)]
× p(γj1; θ)dγj1. (1.20)
The marginal log-likelihood for the observed data at all centers is then given by:
log l(ω,βk, λ0k) =
J∑
j=1
nj∑
i=1
(
2∑
k=1
∆ik(t){log λ0k(ti)+{βTkXi}})+log
∫
Kj(zj, t)p(zj; θ)dzj
where zj = log γj1, and
Kj(z, t) = z
∑nj
i=1Ni1(t−)+ωNi2(t−)
j
×exp
−zj
 t∫
0
Yi(u)λ02(u) exp{βT2Xi}du
− zωj
 t∫
0
Yi(u)λ02(u) exp{βT2Xi}du
 .
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1.3.1 Correlation Score Test
Using the above formulation, the score test for correlation of the two cause-specific
hazards tests H0 : ω = 0. The score function is:
Uω(ω,βk, λ0k) =
∑
j
∫ {∑nji=1 Ni2(ti)− (∫ t0 Yi(u)λ02(u) exp{βT2Xi}du)}zωj log zjKj(zj)p(zj; θ)dzj∫
Kj(zj)p(zj; θ)dzj
Setting ω = 0 and replacing βk, λ0k and θ with their estimates when ω = 0, we have:
Uω(ω,βk, λ0k) =
∑
j
∫ {∑nji=1Ni2(ti)− (∫ t0 Yi(u)λˆ02(u) exp{βˆT2Xi}du)} log zjKˆj(zj)p(zj; θˆ)dzj∫
Kˆj(zj)p(zj; θ)dzj
=
∑
j
M̂2j.l̂og zj
M̂2j is an estimate of the {
∑nj
i=1Ni2(ti) − (
∫ t
0
Yi(u)λ02(u) exp{βT2Xi}du)}, the sum
of the martingale residuals for cause 2 at center j; and l̂og zj = E[log zj|Oj], i.e., the
posterior expectation of the log frailties given the observed data in center j, Oj. If
the frailties zj are assumed to follow a log normal distribution, there is no closed form
expression for l̂og zj, however we can use the estimates γˆj1 obtained by maximizing
the penalized partial log-likelihood for cause 1. Balan et al. (2016) note that the test
of H0 : ω = 0 can be carried out by testing if M̂2j and l̂og zj are correlated. Thus,
the correlation score test (CST) tests if there is a linear dependency between M̂2j
and l̂og zj and uses the regular t statistic from linear regression as the test statistic,
t = r
√
(J − 2)/(1− r2). Under H0 : ω = 0, asymptotically, t follows a t distribution
with J − 2 degrees of freedom.
1.4 Simulation Studies
In the first (of two) set of simulations, we evaluated the fixed effect parame-
ter estimators, variance components of the random effects, and Correlation Score
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Test. There were K = 2 competing risks, and J = 50 or J = 100 centers (con-
figurations 1 and 2, respectively). The center-specific random effects γj1, γj2 fol-
lowed a mean zero multivariate normal (MVN) distribution with variance components
σj = (σ
2
1, σ
2
2, ρ12) = (0.25, 0.25,−0.5). Using the re-parameterization described in
Sections 1.2.1 and 1.2.2, this corresponds to the center-specific random effects vector
bj = (b
0
j , b
1
j , b
2
j) being generated from a MVN with mean zero and diagonal covariance
matrix D with elements θj = (θ0, θ1, θ2) = (0.125, 0.125, 0.125). The sample size
within each center was fixed at nj = 20 or nj = 50 for different sub-configurations.
In addition, we considered a single N(0, 1) covariate Xi with regression coefficients
β1 = 0.5 and β2 = 1.25 for causes k = 1 and k = 2 respectively. Given βk,γj and the
covariate Xi we generated a failure time T
0
i for each subject within center j from an
exponential distribution with rate parameter µ =
∑2
k=1 µk =
∑2
k=1 exp(βkXi + γjk).
We assigned a cause of failure for subject i in center j given a failure at time t using
Pr(∆i = k|T 0i = t) = µk/µ. Finally, all censoring occurred at time τ = 0.4 in all
configurations.
As shown in Table 1.1, the proposed method performs very well in estimating the
parameters of interest. Also in Table 1.1, we present results of simulations where the
center-specific random effects γj1, γj2 were generated from a mean zero MVN with
σj = (σ
2
1, σ
2
2, ρ12) = (0.25, 0.25, 0), in order to assess the loss in efficiency due to
unnecessarily estimating a correlation parameter when the true random effects are
not correlated.
In Table 1.2, we evaluate the proposed CST and a likelihood ratio test (LRT)
of the correlation between cause-specific hazards, via H0 : ρ = 0. For each (J, nj)
configuration, the Type 1 error rate was calculated as the mean number of times
H0 when the random effects were generated from a mean zero MVN with σj =
(0.25, 0.25, 0). Similarly, the Power was the mean number of rejections when the
random effects were generated from a mean zero MVN with σj = (0.25, 0.25,−0.5).
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Table 1.1: Estimating Regression Coefficients and Variance Components: Results
from 500 Simulated Datasets
J nj
True
Value Bias ESD CP
True
Value Bias ESD CP
50 20 β1 0.5 0.007 0.075 0.946 0.5 0.000 0.075 0.954
β2 1.25 0.002 0.072 0.950 1.25 0.002 0.074 0.942
θ1 0.125 -0.003 0.068 – 0 0.022 0.036 –
θ2 0.125 -0.001 0.088 – 0.125 -0.027 0.095 –
θ3 0.125 0.005 0.087 – 0.125 -0.021 0.089 –
50 50 β1 0.5 -0.001 0.043 0.962 0.5 -0.001 0.043 0.962
β2 1.25 0.000 0.044 0.954 1.25 -0.004 0.046 0.944
θ1 0.125 -0.002 0.051 – 0 0.020 0.027 –
θ2 0.125 0.003 0.066 – 0.125 -0.020 0.073 –
θ3 0.125 -0.004 0.057 – 0.125 -0.026 0.069 –
100 20 β1 0.5 0.003 0.050 0.960 0.5 0.000 0.051 0.960
β2 1.25 0.001 0.051 0.946 1.25 0.001 0.053 0.942
θ1 0.125 -0.005 0.053 – 0 0.017 0.029 –
θ2 0.125 0.003 0.066 – 0.125 -0.019 0.074 –
θ3 0.125 -0.001 0.064 – 0.125 -0.021 0.065 –
100 50 β1 0.5 0.001 0.032 0.942 0.5 -0.001 0.033 0.944
β2 1.25 0.000 0.031 0.952 1.25 0.002 0.030 0.964
θ1 0.125 0.002 0.037 – 0 0.015 0.023 –
θ2 0.125 -0.001 0.043 – 0.125 -0.017 0.053 –
θ3 0.125 0.000 0.041 – 0.125 -0.012 0.049 –
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Table 1.2: Power and Type I error of proposed Correlation Score Test (CST), and
Likelihood Ratio (LR) tests. The null hypothesis is no correlation between cause-
specific hazards within center: Results from 500 Simulated Datasets
Number of Centers Subjects per Center Type I Error Power
(J) (nj) LRT CST LRT CST
50 20 0.006 0.032 0.416 0.358
50 50 0.028 0.026 0.782 0.692
100 20 0.022 0.048 0.710 0.654
100 20 0.034 0.036 0.982 0.960
The CST seems to do almost as well as the LRT, attaining a type I error rate closer
to the nominal 0.05 and achieving nearly as much power. More importantly, the CST
is carried out in much less computation time, since it does not require fitting the full
model.
In the second simulation study, we evaluated our estimators of the center-specific
random effects {γj1, γj2}. Again, K = 2, J = 50, and Xi ∼ N(0, 1) with regression
coefficients β1 = 0.5 and β2 = 1.25 for k = 1 and k = 2 respectively. Of the 50 centers,
we fixed the value of the random effects for center j′ and allowed the random effects
for the remaining 49 centers to come from a mean 0 MVN with σj = (σ
2
1, σ
2
2, ρ12) =
(0.25, 0.25,−0.5). The sample size for each of these 49 centers, nj, j 6= j′ was set equal
to the random draw from a N(100, 402) variate bounded at 20. Given βk,γj and Xi,
we generated T 0i from an exponential distribution with rate parameter µi =
∑2
k=1 µik,
where µik = exp(βkXi + γjk), and assigned a cause of failure using Pr(∆i = k|T 0i =
t) = µik/µ. Censoring again occurred at time τ = 0.4.
We studied the performance of our estimators at different values of the random
effects {γj′1, γj′2} and at different nj′ values. We compared the proposed method to
an approach that fits separate frailty models for each k and therefore ignores the
correlation between the center-specific random effects. As shown in Table 1.3, the
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proposed method produces center effect estimates with smaller mean square error,
regardless of the center size and effect.
An expanded version of Table 1.3 is made available in Appendix (see Table A.1).
While both methods produce shrinkage, leveraging information on the correlation
structure of the center-specific random effects leads to estimates with reduced shrink-
age and higher rates of coverage. These gains in bias and coverage become more
pronounced with decreasing sample sizes, and as the true values of the center effects
deviate from the mean of the random effect distribution.
To examine our proposed excess cumulative incidence (ECI) center effect measure,
we conducted simulations where the center-specific effects {γj1, γj2} were known for
all centers. We set J = 50, with nj set equal to the maximum of 20 and a N(100, 40
2)
variate. Center-specific effects {γj1, γj2} were each fixed at one realization from a
MVN with mean 0 and σj = (σ
2
1, σ
2
2, ρ12) = (0.25, 0.25,−0.5); theses were then treated
as true center effects. We set Xi ∼ N(0, 1), with β1 = 0.5 and β2 = 1.25 for causes 1
and 2 respectively. Failure times and causes were then generated as presented earlier.
Censoring was again at τ = 0.4. The true ECI for each center was calculated at
t = 0.3. In Table 1.4, we compare the proposed method with fitting separate cause-
specific Cox frailty models. In terms of mean squared error of the ECI estimates, the
proposed method generally out-performs the separate-models approach. A striking
example, from Table 1.4, is the ECI estimates for Center j = 23, whose true ECI
values for cause 1 and cause 2 are at opposite extremes.
1.5 Application
We applied the proposed methods to evaluate Organ Procurement Organizations
(OPOs) with respect to two competing risks: (i) deceased-donor kidney transplanta-
tion (ii) death (prior to transplantation). We use data from the Scientific Registry of
Transplant Recipients (SRTR). The SRTR data system includes data on all donor,
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Table 1.3: Estimating Center-Specific Effects: Results from 500 Simulations
Proposed Method
Ignornig Correaltion
of Random Effects
nj′
True
Value Bias ESD ASE CP Relative MSE
20 γj′1 0.0 -0.019 0.231 0.322 0.988 1.113
γj′2 0.0 -0.015 0.239 0.305 0.980 1.084
γj′1 0.5 -0.175 0.241 0.297 0.970 1.232
γj′2 -0.5 0.168 0.249 0.327 0.972 1.248
γj′1 1.0 -0.276 0.244 0.276 0.870 1.252
γj′2 -1.0 0.397 0.244 0.354 0.838 1.700
40 γj′1 0.0 -0.007 0.222 0.263 0.988 1.093
γj′2 0.0 -0.015 0.209 0.243 0.986 1.041
γj′1 0.5 -0.097 0.208 0.232 0.946 1.203
γj′2 -0.5 0.108 0.214 0.271 0.974 1.274
γj′1 1.0 -0.141 0.203 0.209 0.916 1.242
γj′2 -1.0 0.268 0.221 0.306 0.914 1.799
60 γj′1 0.0 -0.010 0.202 0.231 0.968 1.098
γj′2 0.0 -0.005 0.187 0.210 0.976 1.074
γj′1 0.5 -0.066 0.195 0.200 0.962 1.142
γj′2 -0.5 0.070 0.209 0.240 0.958 1.148
γj′1 1.0 -0.097 0.168 0.178 0.948 1.227
γj′2 -1.0 0.219 0.219 0.276 0.890 1.666
80 γj′1 0.0 -0.018 0.181 0.210 0.988 1.095
γj′2 0.0 -0.020 0.179 0.191 0.964 1.080
γj′1 0.5 -0.071 0.180 0.180 0.954 1.170
γj′2 -0.5 0.066 0.180 0.218 0.970 1.153
γj′1 1.0 -0.105 0.161 0.161 0.894 1.206
γj′2 -1.0 0.193 0.201 0.256 0.918 1.554
100 γj′1 0.0 -0.020 0.170 0.194 0.976 1.095
γj′2 0.0 -0.015 0.157 0.176 0.978 1.065
γj′1 0.5 -0.076 0.15 0.167 0.964 1.171
γj′2 -0.5 0.059 0.197 0.203 0.932 1.123
γj′1 1.0 -0.095 0.141 0.149 0.928 1.218
γj′2 -1.0 0.155 0.196 0.242 0.944 1.494
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Table 1.4: Estimating Excess Cumulative Incidence: Results from 500 Simulation
Proposed Method
Ignornig Correlation
of Random Effects
Cause Center
True
Value Bias ESD ASE CP Relative MSE
1 14 -0.170 0.029 0.022 0.027 0.850 1.018
16 -0.096 0.024 0.029 0.034 0.926 0.750
17 -0.181 0.003 0.017 0.023 0.990 3.432
38 -0.138 0.017 0.024 0.029 0.958 1.226
1 -0.179 0.023 0.020 0.026 0.918 1.462
36 0.006 -0.009 0.038 0.038 0.932 0.950
4 -0.033 0.001 0.034 0.037 0.948 1.010
49 -0.070 0.018 0.029 0.034 0.944 0.777
32 -0.047 0.010 0.031 0.035 0.960 0.969
34 0.005 0.001 0.035 0.039 0.948 1.028
23 0.344 -0.022 0.045 0.047 0.934 1.279
19 0.118 -0.013 0.043 0.045 0.904 0.939
13 0.142 -0.015 0.044 0.046 0.942 1.036
15 0.127 -0.007 0.043 0.044 0.938 1.082
18 0.210 -0.022 0.047 0.048 0.904 0.988
2 26 -0.222 0.020 0.019 0.025 0.932 2.265
25 -0.140 0.014 0.027 0.029 0.936 1.196
20 -0.137 0.013 0.025 0.030 0.952 1.209
23 -0.199 0.014 0.021 0.025 0.950 2.122
5 -0.078 0.006 0.030 0.032 0.950 1.056
29 -0.017 0.004 0.034 0.033 0.922 0.954
11 -0.020 0.002 0.031 0.034 0.954 0.987
45 -0.043 0.006 0.032 0.033 0.934 0.965
34 -0.058 0.007 0.029 0.033 0.952 0.993
9 -0.009 0.001 0.031 0.033 0.946 1.016
41 0.203 -0.016 0.037 0.037 0.928 1.065
40 0.158 -0.012 0.035 0.036 0.934 1.076
31 0.157 -0.016 0.038 0.038 0.900 0.969
17 0.371 -0.020 0.037 0.034 0.902 1.327
14 0.111 -0.009 0.033 0.035 0.926 1.245
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wait-listed candidates, and transplant recipients in the U.S., submitted by the mem-
bers of the Organ Procurement and Transplantation Network (OPTN), and has been
described elsewhere. The Health Resources and Services Administration (HRSA),
U.S. Department of Health and Human Services provides oversight to the activities
of the OPTN and SRTR contractors.
The study cohort included patients wait-listed between 1/1/2010 and 4/30/2010.
Patients were followed from the date of listing until the earliest of receipt of a kid-
ney transplant, death, removal from wait-list, or the end of the observation period,
12/31/2012. Using the proposed methods, we compared OPOs across the U.S. with
respect to the cumulative incidence of receiving a deceased-donor transplant and the
cumulative incidence of death prior to transplantation. The time point we chose was
two years post wait-listing, an appropriate time horizon based on previous related
analyses (e.g., Fan and Schaubel, 2016). Patients receiving a living donor transplant
were treated as independently censored, which is appropriate from the perspective
that living-donor transplantation depends on many factors related to a patient’s spe-
cific circumstances and largely independent of OPO. Note that living-donor trans-
plantation was not a cause of our interest, rendering unappealing its inclusion as a
separate cause.
Our study population included n = 11, 759 patients across J = 58 OPOs across the
U.S. A total of 2,408 patients (20.5%) received a deceased-donor kidney transplant,
while 1,114 (9.5%) died first. We adjusted for the following patient-level covariates:
age at listing, race, sex, body mass index, primary renal diagnosis, panel reactive
antibody level and blood type. Owing to the large dimension of the covariate vector,
we used a two-stage approach, as done in Kalbfleisch and Wolfe (2013), to obtain
the risk-adjusted center effects (see also He and Schaubel, 2014b). Specifically, we
estimated the patient-level covariates at the first stage by fitting a Cox model stratified
by OPO. At the second stage, we estimated the cause-specific OPO effects by fitting
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the proposed model, using the patient-level linear predictor from the first stage as
an offset. The estimated variance components are given by σˆj = (σˆ
2
1, σˆ
2
2, ρˆ12) =
(0.619, 0.031, 0.210). The estimated correlation was determined to be statistically
significant, with the CST yielding a p-value of 0.021.
Figure 1 displays the estimated OPO-specific ECI’s at 2 years post-listing, along
with 95% confidence intervals. The ECIs of transplantation ranged from -0.120 to
0.404, and the ECIs of death ranged from -0.126 to 0.115. For a given OPO, a high
ECI for transplantation and a low ECI for death represent good performance. We
classified OPOs as low- or high-outliers based on the 95% confidence intervals.
We compared the proposed method to a method that ignores the correlation be-
tween the cause-specific center effects with respect to outlier classification (Table A.2).
While the two methods produced nearly identical classifications of OPOs based on
the incidence of transplant, the proposed method classified 6 more OPOs as outliers
than fitting separate frailty models by cause. This is a consequence of the reduction
in shrinkage in the ECI estimates by the proposed method, due to leveraging the
information on the correlation structure.
1.6 Discussion
In this chapter, we develop methods for evaluating center performance in the
competing risks setting. We propose estimating center effects through cause-specific
proportional hazards frailty models that allow correlation among a centers cause-
specific hazards. We also propose a score test to test for the presence of correlation
between a center’s cause-specific hazards.
In our application, the cause-specific center effects do not seem to be strongly
correlated. In scenarios where the correlation between cause-specific center effects is
on the higher side, as maybe the case, for example, if there exists an unmeasured
covariate influencing both outcomes, using the proposed method instead of currently
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Figure 1.1: Analysis of Scientific Registry of Transplant Recipients (SRTR) Data:
Caterpillar Plots of Excess Cause-specific Cumuluative Incidence of Death and Kidney
Transplantation for 58 Organ Procurement Organizations
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available methods may produce a larger change in classification of centers than seen
here. Since fitting the proposed model may be computationally cumbersome, we
recommend first using the proposed CST, to determine if the proposed model is
warranted (the alternative being cause-specific frailty models).
As mentioned in Section 1.2.1, we assume that the patient-level covariates and
center-level random-effects are uncorrelated. In practice, covariates and random-
effects may be correlated, for example, sicker patients may prefer a center whose
case-mix adjusted outcomes are better. This violation of our model assumption will
lead to biased estimates of fixed effect parameters and consequently the center-level
random effects in our model. In our application, to avoid problems due to confounding
between the patient-level covariates and the OPO-specifc random-effects, we use a
two-stage approach to estimate the center random effects. In the first stage, we fit
a model stratified by OPO to estimate the regression parameters associated with a
large number of patient characteristics. In the second stage, we use the estimated
regression parameters as an offset in the linear predictor of the instantaneous hazard
in a random-effects model, that is, we estimate the random effects given Xβˆ, where
βˆ is estimated from the stratified model. This ensures that an unbiased estimate
of βˆ is used while estimating the random effects. Apart from accommodating for
confounding by patient-level covariates, the two-stage approach has an added benefit
of easing computational burden. Given the potential for confounding by patient-level
covariates, especially, in studies of center performance, we strongly recommend the
use of the two-stage approach in lieu of a joint estimation approach which ignores the
problem of confounding and is thereby bound to produce biased estimates of center
effects.
The random effects estimated using our proposed two-stage approach represent
an estimate of variation between centers after all the within center variation has been
accounted for accurately. It is possible that the random-effects may still be correlated
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with center-level averages of the covariates X, and that this variation could further be
partitioned into variation due to differences in center-level averages of the covariates
X and other remaining variation between centers. The question of adjusting further
for between-center differences while using a random-effects model may be a policy
decision rather than a methodological decision. Further adjustment for between-
center differences can be done using the between-method decomposition of covariates
as suggested by Sjo¨lander et al. (2013), where center-level averages of the covariates
X are included as predictors.
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CHAPTER II
A semiparametric mixture component model with
random effects for the analysis of clustered
competing risks data
2.1 Introduction
Competing risks data are encountered in biomedical studies when subjects are
subject to failure from many distinct causes or events. Our work here is motivated by
data arising from the end-stage renal disease (ESRD) setting where medically suitable
patients in need of a kidney transplant are placed on a waiting list. For our purposes,
this is when follow-up begins. While on the wait list, these patients may die before
receiving a transplant. In this case, the competing events are: (i) receipt of a kidney
transplant and (ii) pre-transplantation death while on the wait list.
In many situations, competing risks data cannot be considered independent and
appropriate methods are needed to account for the correlation across subjects. This is
also the case in our motivating application, since patients are clustered within trans-
plant centers, i.e., the center where the patient’s wait list registration was initiated.
In this chapter, we develop a method for the simultaneous analysis of the absolute
risk of different competing events in the ESRD setting, taking into consideration the
correlation of failure times across patients within the same transplant center.
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Early work on analyzing competing risks data was mostly focused on the es-
timation and modeling of cause-specific hazards or the instantaneous risk of an
event (Prentice and Kalbfleisch, 1978). Let T denote the time to first event and
 ∈ {1, ..., K} denote the cause or type of failure, with K being the number of
distinct causes. Then, the cause-specific hazard for an event  = k at time t is
λk(t) = lim∆t→0 Pr(t ≤ T < T + ∆t,  = k)/(∆t). Another identifiable quantity from
competing risks data (T, ) is the subdistribution or cumulative incidence function
for cause k: Fk(t) = Pr(T ≤ t,  = k). The cumulative incidence function mea-
sures the absolute event-specific risk and presents a scientifically relevant alternative
to the cause-specific hazard function. Given its scientific relevance, direct modeling
of covariate effects on the cumulative incidence function has received a lot of focus
recently. Fine and Gray (1999), building on earlier work by Gray (1988) proposed
a Cox proportional hazards model for the subdistribution hazards; while, Sun et al.
(2006) explored an additive hazards model. Andersen et al. (2003) and Klein and
Anderson (2005) proposed a regression technique that utilizes pseudovalues from a
jackknife statistic constructed from the cumulative incidence curve in a generalized
estimating equation for estimation of covariate effects. Jeong and Fine (2007) pro-
posed parametric regression of the cumulative incidence functions using a simple form
of the Gompertz distribution for the log of the baseline cumulative subdistribution
hazard function. Scheike et al. (2008) proposed direct binomial regression of the
cumulative incidence function through a flexible semiparametric model where some
covariates have time-varying effects and others have constant effects.
The aforementioned methods focus on estimating covariate effects on the cumu-
lative incidence function of a primary cause of interest only, allowing an arbitrary
structure for other causes. Oftentimes, investigators may be interested in simultane-
ous analysis of the different causes and their interrelationship. In such cases, fitting
the aforementioned models separately by cause may not be desirable as information
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on between cause association is generally not available. Recently, Mao and Lin (2016)
developed a method based on semi-parametric transformation models that permits
joint inference on all competing events. Another joint modeling approach, studied by
Huang and Zhang (2008) and Chen (2010) takes into account the relationships among
failure times through an assumed copula. Yet, none of the methods mentioned so far
explicitly address the additivity constraint for the cumulative incidence functions,∑
k Pr( = k) = 1, that is, the constraint that a subject must eventually fail from
one and only one of the distinct causes.
The additivity constraint can be explicitly incorporated by employing a mixture
regression modeling framework. For example, Larson and Dinse (1985), Maller and
Zhou (2002), Lu and Peng (2008) and Choi and Huang (2014) use the mixture model
approach to decompose the model for cumulative incidence functions into a model for
failure time conditional on the cause of failure, Pr(T ≤ t| = k), and a model for the
marginal probability of the cause of failure, Pr( = k). Here, we use the mixture re-
gression modeling framework to develop semiparametric models for the cause-specific
cumulative incidence functions in the clustered competing risks data setting.
In many applications, competing risks data cannot be considered independent. For
instance, data from multicenter clinical trials and familial studies consist of clustered
subjects whose failure time distributions may be correlated. The analysis of clustered
competing risks data present two major challenges. First, methodologies developed
for clustered single failure time data are not directly applicable to the competing risks
setting. Second, methods need to appropriately account for correlation of event times
among subjects within the same cluster. Methods developed for analyzing clustered
competing risks data can broadly be categorized into: (1) methods designed for esti-
mation and inference of appropriately defined measures of associations among failure
times within clusters; and (2) regression methods for assessing covariate effects while
accounting for within-cluster correlation of event times.
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For measuring the association of the cause-specific failure times within a cluster,
Bandeen-Roche and Liang (2002) introduced a nonparametric cause-specific cross
hazard ratio for bivariate competing risks data; Cheng and Fine (2008) proposed
an alternative representation using bivariate hazard functions. Cheng et al. (2007)
derived nonparametric estimators of bivariate cause-specific hazard and cumulative
incidence functions, and proposed two association measures in terms of these bivari-
ate functions. These and a few other methods (Cheng 2010), do not accommodate
covariate effects and require joint cause-specific intensities to be specified for all cause
combinations. Scheike and Sun (2012) proposed a parametric regression model to es-
timate covariate effects on the cross-odds ratio for multivariate competing risks data.
The cross odds ratio is a measure of association between cause-specific failure times
within a cluster that can be represented in terms of the bivariate and univariate cu-
mulative incidence functions.
Methods for regression analysis of clustered competing risks data can be divided
into methods based on marginal and conditional approaches. Marginal approaches fo-
cus on estimating marginal effects of covariates from a population average regression
model while accounting for the dependence across individuals within a cluster. For
example, Zhou et al. (2012) proposed an extension of the proportional subdistribu-
tion hazards model with sandwich-type variance estimators to account for correlation
within clusters. Conditional approaches, on the other hand, seek to estimate both
the covariate effects and the within-cluster associations. Katsahian et al. (2006) and
Katsahian and Bodreau (2011) extended the Fine-Gray proportional subdistribution
hazards model for the clustered data setting by including a cluster-specific frailty or
random-effect term. Scheike et al. (2010) proposed an alternative semiparametric
random effects model under which the marginal model for the cumulative incidence
function does not depend on the distribution of the random effects. These studies
propose modeling strategies to estimate covariate and clustering effects on the abso-
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lute risk of a single, primary cause of interest. If interest lies in assessing multiple
causes, their models should be fitted repeatedly, focusing on each event separately.
However, given that the additivity constraint is not explicitly addressed, these models
may not hold simultaneously, making them difficult to interpret and unreliable for
prediction purposes.
In this chapter we develop a semiparametric random effects model for the anal-
ysis of clustered competing risks data. Our method permits simultaneous inference
of covariate effects on all competing risks and allows for correlation of failure times
across subjects within a cluster. The dependence parameters in our model has an
interpretation as a measure of association of failure times across subjects within a
cluster. In the subsequent sections, we first introduce some notations and describe
our modeling approach. Then, we describe an inference procedure for (i) regression
parameters of the marginal model measuring covariate effects and (ii) the dependence
parameters measuring the effect of clustering.
2.2 Setup and Model
Assume that there are n study subjects in total and that each comes from one of
J centers or clusters (hereafter, we use the two terms interchangeably). Each center
j , has nj members, such that
∑J
j=1 nj = n. For each subject i(i = 1, ..., nj) in cluster
j, let Tij and Cij denote the failure time and the censoring time, respectively. Let Xij
be a vector of subject-specific time-independent covariates and let Wij be another
covariate vector that includes 1 and may share some common components with Xij.
Assuming each subject fails due to one and only one ofK causes, we let ij ∈ {1, ..., K}
denote the cause of failure, Nijk(t) = I(Tij ≤ t, ij = k) be the counting process for
cause k, and let ∆ij = I(Tij ≤ Cij) be the observed-event indicator. Observed data for
each subject i in cluster j then consist of {Xij,Wij, T˜ij, ˜ij}, where T˜ij = min (Tij, Cij)
is the observed event time, and ˜ij = ∆ijij is the observed event indicator.
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Further, to incorporate the additive constraint, we propose using the mixture
model representation for competing risks. In particular, the model for cause-specific
cumulative incidence functions is decomposed into a model for the distribution of
ij given the covariate vector Wij, Pr(ij = k|Wij), and a model for conditional
cumulative incidence function Pr(Tij ≤ t|ij = k,Xij). We adapt this approach to
the clustered data setting by including cluster-specific random effects in the models for
conditional cumulative incidence functions. Specifically,for the jth center, we define
a center-specific random effect aj affecting the model for the distribution of ij and
a K-variate vector of center-specific random effects or frailties, bj = (bj1, ..., bjK)
T
affecting model for conditional cumulative incidence function. Given these center-
specific random effects, the event times for all subjects within that center are assumed
to be conditionally independent.
For ease of representation and without loss of generality, we write down our models
and describe our estimation procedure for K = 2, such that ij ∈ {1, 2}. We propose
the following probit regression model for the marginal distribution of ij given the
covariate vector Wij,
pik(Wij, aj) = Pr(ij = k|Wij, aj) = Φ((−1)k−1(γTWij + aj)), k ∈ {1, 2}, (2.1)
where Φ is the cumulative distribution function for a standard Normal variable. We
assume the following model for conditional cumulative incidence functions:
Pr(Tij ≤ t|ij = k,Xij, bjk) = 1− exp{−bjkt− ηk(t)− βTkXijt}, k ∈ {1, 2}. (2.2)
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This leads us to the following random effects model for the cause-specific cumulative
incidence function in the presence of clustering:
Fijk(t|bjk,Xij, aj,Wij) = pik(Wij, aj)(1− exp{−bjkt− ηk(t)− βTkXijt}), k ∈ {1, 2}.
(2.3)
Note that the additivity constraint is satisfied as
∑2
k=1 pik(Wij) = 1 by design.
We assume that the center-specific random effect terms, aj, in the probit regres-
sion model for the marginal distribution of ij are uncorrelated with the random
effect terms bj = (bj1, ..., bjK)
T in the additive hazards model for conditional cumu-
lative incidence functions. Further, we assume that all random effects are normally
distributed, such that, aj ∼ N(0, θa) and
bj =
bj1
bj2
 ∼MVN(
0
0
 ,
θb11 θb12
θb12 θb22
).
Then, under model (3), the marginal cumulative incidence function can be written
as:
Fijk(t|Xij,Wij) = p˜ik(Wij)(1− exp{−Hk(t)− βTkXijt})
where p˜ik(Wij) = Eθa [Φ((−1)k−1(γTWij + aj))] = Φ((−1)k−1γ˜TWij), and Hk(t) =
ηk(t) − log(Eθbkk [exp(−bjkt)]). Note that a conditional probit model with Normal
random effects when marginalized yields a probit model with fixed-effect parameters
equal to the corresponding parameters in the conditional model scaled by
√
(1 + θa),
that is, γ˜ = γ/
√
(1 + θa).
We employ a two-stage estimation procedure for the parameters in model (3). In
the first stage, we estimate parameters of marginal model (4), namely γ, θa,βk and
Hk(t) and, in the second stage, we estimate the dependence parameters, θb11, θb22, θb12,
for model (3), i.e., the distributional parameters of the cluster-specific random effects
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for both causes. We describe the proposed estimation procedure in the section that
follows.
2.3 Inference Procedures
2.3.1 Estimation of Marginal Model Parameters
Let Gij(t) = Pr(Cij > t|Xij), then observe that, under conditional independence
between Cij and (Tij, ij), we have:
E
[
∆ijNijk(t)
Pr(Cij > t)
]
= E
[
E
{
∆ijNijk(t)
Gij(t)
∣∣∣∣Tij, ij,Xij}] = E(Nijk(t)) = Fijk(t). (2.4)
Scheike et al. (2008) proposed to estimate parameters for a semiparametric regression
model for the cumulative incidence functions by solving estimating equations based
on the weighted response ∆ijNijk(t)/Gij(t). As Gij(t) is usually not known, it could
be substituted with an estimate Gˆij(t) obtained from either a Kaplan-Meier (1958)
estimator of the censoring distribution, or an estimator based on a regression model,
like the Cox (1972) proportional hazards model, relating the censoring distribution to
covariates. Let DHk(t)(t) = ∂F
Hk(t),βk
ijk (t)/∂Hk(t) and Dβk(t) = ∂F
Hk(t),βk
ijk (t)/∂βk(t).
If p˜ik(Wij) were known, the parameters {Hk(t),βk} of the marginal model (3) can be
estimated using the following estimating equations:
UHk(t,Hk(t),βk) =
J∑
j=1
nj∑
i=1
DHk(t)
{
∆ijNik(t)
Gˆij(t)
− Fijk(t)
}
= 0 (2.5)
Uβk(τ,Hk(t),βk) =
J∑
j=1
nj∑
i=1
τ∫
0
Dβk(t)
{
∆ijNijk(t)
Gˆij(t)
− Fijk(t)
}
= 0 (2.6)
However, p˜ik(Wij) is unknown and depends on the unknown parameters {γ, θa}.
To estimate {γ, θa} simultaneously, we propose and approach similar to the general-
ized estimating equations of order 2 (GEE2) approach proposed by Feddag (2014).
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Our estimating equations for {γ, θa} are motivated by examining the conditional
mean and empirical pairwise covariance of ij = k. We first note that ij is not
observed for all subjects. In the case that a subject is censored, i.e., when ˜ij, and
censoring occurs at time T˜ij = t, the probability of ij = 1 conditional on T ≥ t is
denoted by gijk(t;γ,βk, Hk(t),Wij,Xij), where
gijk(t;γ,βk, Hk(t),Wij,Xij) = Pr( = k|Tij > t,Wij,βk, Hk(t))
=
pik(Wij) exp{−Hk(t)− βTkXijt}∑2
k=1 pik(Wij) exp{−Hk(t)− βTkXijt}
.
It follows that:
Pr(ij = k|˜ij, T˜ij = t,Wij,Xij) = E[I(˜ij = k)+I(˜ij = 0)gijk(t;γ,βk, Hk(t),Wij,Xij)].
This leads us to the following first order estimating equation γ based on the condi-
tional mean:
δj1 =
nj∑
i=1
{I(˜ij = k) + I(˜ij = 0)gijk(T˜ij)− p˜ik(Wij)}
The above equation is supplemented with an equation based on the empirical pairwise
covariances within a cluster. Specifically, we define
δj2 =
nj∑
i=1
nj∑
i′=i
∆ij
Gˆij(T˜ij)
∆i′j
Gˆij(T˜i′j)
{
I(ij = 1)I(i′j = 1)−
Eθa [Φ((−1)k−1(γTWij + aj))Φ((−1)k−1(γTWi′j + aj))]
}
Estimates of γ, θa are then obtained by solving:
Uγ,θa = D
T
J∑
j=1
[δj1, δj2]
T = 0 (2.7)
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where D is a matrix of derivatives, such that:
D =
∂δj1∂γ ∂δj1∂θa
∂δj2
∂γ
∂δj2
∂θa
 .
The regression parameters of the marginal model can be estimated by starting with
arbitrary initial values and solving the above estimating equations (2.5), (2.6) and
(2.7) using an iterative algorithm until a pre-specified convergence criterion is satis-
fied. Upon convergence, we obtain estimators of γ, θa,βk, Hk, denoted by γˆ, θˆa, βˆk, Hˆk
respectively.
2.3.2 Estimation of Dependence Parameters
To estimate dependence parameters {θb11, θb22, θb22}, we consider cross-moments
between a pair of subjects i, i′ within the same cluster, say j, experiencing a pair of
causes k, k′, where k ∈ 1, 2, k′ ∈ 1, 2. Let:
Vii′,j,kk′(t) = (Gˆij(t))
−1∆ijNijk(t)(Gˆi′j(t))−1∆i′jNi′jk′(t) (2.8)
Let vii′,j,kk′(t) = E{Vii′,j,kk′(t)} = E{(Gˆij(t))−1∆ijNijk(t)(Gˆi′j(t))−1∆i′jNi′jk′(t)}. As
noted in Section 2, in our model, the cause-specific random effects within center j
follows a multivariate normal distribution with V ar(bj1) = θb11, V ar(bj2) = θb22 and
Cov(bj1, bj2) = θb12. It follows that:
vii′,j,12(t) = Eθa [pi1j(Wij, aj)pi2j(Wi′j, aj)](1− exp{−H1(t)−βT1Xijt}− exp{−H2(t)
− βT2Xi′jt}+ exp{θ12t2 −H1(t)− βT1Xijt−H2(t)− βT2Xi′jt})
vii′,j,11(t) = Eθa [pi1j(Wij, aj)pi1j(Wi′j, aj)](1− exp{−H1(t)−βT1Xijt}− exp{−H1(t)
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− βT1Xi′jt}+ exp{θ1t2 −H1(t)− βT1Xijt−H1(t)− βT1Xi′jt})
vii′,j,22(t) = Eθa [pi2j(Wij, aj)pi2j(Wi′j, aj)](1− exp{−H2(t)−βT2Xijt}− exp{−H2(t)
− βT2Xi′jt}+ exp{θ2t2 −H2(t)− βT2Xijt−H2(t)− βT2Xi′jt})
Let Ij denote the set index for jth cluster, the above results leads us to consider the
following estimating equations for the dependence parameters:
Uθ12(τ, θˆa, γˆ, Hˆ1, βˆ1, Hˆ2, βˆ2, Gˆ) =
τ∫
0
J∑
j=1
∑
i,i′∈Ij ,i 6=i′
{Vˆii′,j,12(t)− vii′,j,12(t, θ12, θˆa, γˆ, Hˆ1, βˆ1, Hˆ2, βˆ2)}dt = 0 (2.9)
Uθ1(τ, θˆa, γˆ, Hˆ1, βˆ1, Gˆ) =
τ∫
0
J∑
j=1
∑
i,i′∈Ij ,i<i′
{Vˆii′,j,11(t)−vii′,j,11(t, θ1, θˆa, γˆ, Hˆ1, βˆ1)}dt = 0
(2.10)
Uθ2(τ, θˆa, γˆ, Hˆ2, βˆ2, Gˆ) =
τ∫
0
J∑
j=1
∑
i,i′∈Ij ,i<i′
{Vˆii′,j,22(t)−vii′,j,22(t, θ2, θˆa, γˆ, Hˆ2, βˆ2)}dt = 0
(2.11)
We denote the estimators obtained by solving equations (2.9), (2.10) and (2.11) as
θˆ12, θˆ1 and θˆ2 respectively.
2.3.3 Variance Estimation using perturbation resampling
To estimate the variance and to construct confidence intervals for our proposed es-
timators, we use a perturbation-based resampling method. We apply perturbing ran-
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dom variables directly to the estimating functions at the cluster-level to approximate
the distribution of the aforementioned estimators. Specifically, let {ξj, j = 1, ..., J}
be J independent copies of a positive random variable ξ from a known distribution
with unit mean and unit variance. Fixing the data at their observed values, per-
turbed estimators are obtained as the solution to the following perturbed estimating
functions:
U∗Hk(t,Hk(t),βk) =
J∑
j=1
ξj
nj∑
i=1
DHk(t)
{
∆ijNik(t)
G∗ij(t)
− Fijk(t)
}
= 0 (2.12)
U∗βk(τ,Hk(t),βk) =
J∑
j=1
ξj
nj∑
i=1
τ∫
0
Dβk(t)
{
∆ijNijk(t)
G∗ij(t)
− Fijk(t)
}
= 0 (2.13)
U∗γ,θa = D
T
J∑
j=1
ξj[δj1, δj2]
T = 0 (2.14)
U∗θ12(τ,γ
∗, H∗1 ,β
∗
1, H
∗
2 ,β
∗
2, G
∗) =
τ∫
0
J∑
j=1
ξj
∑
i,i′∈Ij ,i 6=i′
{V ∗ii′,j,12(t)− vii′,j,12(t, θ12, θ∗a,γ∗, H∗1 ,β∗1, H∗2 ,β∗2)}dt = 0 (2.15)
U∗θ1(τ,γ
∗, H∗1 ,β
∗
1, G
∗) =
τ∫
0
J∑
j=1
ξj
∑
i,i′∈Ij ,i<i′
{V ∗ii′,j,11(t)−vii′,j,11(t, θ1, θ∗a,γ∗, H∗1 ,β∗1)}dt = 0
(2.16)
U∗θ2(τ,γ
∗, H∗2 ,β
∗
2, G
∗) =
τ∫
0
J∑
j=1
ξj
∑
i,i′∈Ij ,i<i′
{V ∗ii′,j,22(t)−vii′,j,22(t, θ2, θ∗a,γ∗, H∗2 ,β∗2)}dt = 0
(2.17)
where G∗ is the perturbed version of Gˆ, an estimator of the censoring distribution with
weights {ξj, j = 1, ..., J}, and V ∗ii′,j,kk′(t) = (G∗ij(t)−1∆ijNijk(t)(G∗ij(t))−1∆i′jNi′jk′(t).
The above perturbed estimating equations (2.12)-(2.17) are solved using the same pro-
cedures used to solve their unperturbed counterparts, estimating equations (2.5)-(2.7)
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and (2.9)-(2.11), to obtain estimators {γ∗, θ∗a,β∗k, H∗k , θ∗12, θ∗1, θ∗2}. By repeatedly gen-
erating {ξj, j = 1, ..., J}, say M times, we can obtain a large number of realizations
of the perturbed estimators, say - {γ∗(m), θ∗(m)a ,β∗(m)k , H∗(m)k , θ∗(m)12 , θ∗(m)1 , θ∗(m)2 ,m =
1, ....,M}.
It can be shown that the unconditional distribution of estimates {γˆ, θˆa, βˆk, Hˆk, θˆ12, θˆ1, θˆ2}
can be approximated by the conditional distribution of the perturbed estimates given
the observed data (van der Vaart and Wellner, 1996). Thus, the variance and con-
fidence intervals of estimates {γˆ, θˆa, βˆk, Hˆk, θˆ12, θˆ1, θˆ2} are estimated based on the
empirical distribution of {γ∗(m), θ∗(m)a ,β∗(m)k , H∗(m)k , θ∗(m)12 , θ∗(m)1 , θ∗(m)2 ,m = 1, ....,M}.
2.4 Simulation Studies
In this section we describe simulation studies carried out to evaluate our pro-
posed method. For the results presented in Tables 2.1 and 2.2, data were generated
as follows. The failure time Tij for each individual i in center j (j ∈ {1, ..., J})
was generated from model (2.3). First, a cause ij was generated from model (2.1),
where W = {1, Zij} and γ = (γ0, γ1) = (0.5,−0.5); and conditional on cause of
failure a time was generated from model (2.2), where Xij = Zij, β1 = 0.8, β2 =
0.5, η1(t) = t+ 0.5t
2, η2(t) = t+ 0.5t
2. The single covariate Zij was generated from a
Bernoulli distribution with a success probability of 0.5. The cluster-specific random
effects in the probit model (2.1), aj, were generated from a N(0, 0.49) distribution
and the random effects in the model (2.2) for the conditional cumulative incidence,
{(bj1, bj2), j = 1, ....J}, were generated from a multivariate normal distribution with
mean (0, 0) and variance components (θ1, θ2, θ12) = (0.4, 0.4,−0.2). In each case, a
censoring time for each individual was generated dependent on the covariate as follows
Cij ∼ Unif(1, 2) × Zij1 + Unif(0.25, 2) × (1 − Zij1). This setup lead to a censoring
rate of approximately 18%, and an occurrence rate of approximately 47% for cause 1
failures and 35% for cause 2 failures in all sample size configurations.
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Table 2.1: Simulation results for one covariate setting with negatively correlated
cluster-specific random effects
Parameter
True
Value BIAS SD SE CP
γ0 0.5 0.026 0.116 0.111 0.936
γ1 -0.5 -0.011 0.130 0.123 0.928
β1 0.8 -0.002 0.232 0.220 0.940
β2 0.5 0.053 0.251 0.258 0.928
θa 0.49 0.040 0.196 0.189 0.934
θb11 0.5 -0.069 0.321 0.276 0.882
θb22 0.5 -0.075 0.383 0.322 0.870
θb12 -0.25 -0.028 0.408 0.440 0.940
Bias, empirical bias of estimates; SD, empirical standard deviation; SE, mean of estimated standard
error via the proposed resampling method; CP, empirical coverage probability
Tables 2.1 displays the results of our numerical investigations for a setting with
J = 100 clusters and with varying sample size per cluster, generated as nj ∼
Unif{2, 3, 4, 5, 6, 7, 8, 9, 10}. To calculate the asymptotic standard errors of our es-
timators, we used the resampling procedure detailed in Section 2.3. Specifically, for
each simulated dataset we generated M = 100 realizations of {ξj, j = 1, ...., J}; where
ξj were independently distributed unit exponential random variables. Results shown
in Tables 2.1 indicates that our method produces nearly ubiased estimators for both
the marginal model parameters and the dependence parameters. The proposed re-
sampling method produces standard error estimates that are close to the empirical
standard errors and 95% confidence intervals that provide close to nominal coverage.
2.5 Application
We applied our proposed methods to data from the Scientific Registry of Trans-
plant Recipients (SRTR). The SRTR data consist of information on all donors, trans-
plant recipients and candidate patients on wait-lists across the U.S., submitted by
the members of the Organ Procurement and Transplantation Network (OPTN), and
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has been described elsewhere. We specifically studied the outcomes of candidates
wait-listed for a kidney transplant. To this end, the competing events in our analysis
were (i) receipt of a deceased donor kidney transplant (ii) death while on the wait-list.
As mentioned earlier, our data consisted of a natural clustering of patients within
transplant centers. Specifically, our study cohort consisted of 3,114 patients wait
listed for a kidney transplant between January 1st, 2002 and June 30th, 2002, across
52 transplant centers in UNOS Regions 1, 2 and 9. This included all transplant cen-
ters in the states of Connecticut, Delaware, District of Columbia, Maine, Maryland,
Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island,
West Virginia and Vermont. With these 52 transplant centers as the clustering units,
we estimated the effect of patient-level covariates and the effects of clustering on cu-
mulative incidence functions of the two competing events of interest. We followed
patients from the date of listing until the earliest of receipt of a kidney transplant,
death, removal from wait-list, or the end of the observation period, December 31st,
2008. As living-donor transplantation was not a cause of our interest, its inclusion as
a separate cause was not considered and patients receiving a living donor transplant
were treated as independently censored.
Of 3,114 patients, 51.2% received a deceased-donor kidney transplant and 19.2%
died before end of observation period. Our model included following patient-level
covariates for both causes: age at listing, race, sex, body mass index, primary renal
diagnosis, peak renal reactive antibody level and blood type. In Tables 2.2 and 2.3, we
present the results of our analysis. Firstly, we examine the various covariate effects on
the marginal probability of transplantation, denoted by γˆ, and the covariate effects
on conditional cumulative incidence of transplantation, βˆ1, and pre-transplant death,
βˆ2. The reference categories are Caucasian, blood type O, female, glomerulonephritis
for the primary renal disease diagnosis and BMI > 30.
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Table 2.2: Results of application to SRTR data: Covariate Effects
γˆ βˆ1 βˆ2
Covariate Estimate SE Estimate SE Estimate SE
Intercept 2.257 0.268 0 0 0 0
Race
Black -0.283 0.078 -0.117 0.02 -0.023 0.032
Asian 0.001 0.275 -0.184 0.034 -0.095 0.067
Hispanic 0.013 0.162 -0.085 0.033 -0.127 0.04
Other -0.243 0.352 0.099 0.173 0.125 0.179
Blood Type
A 0.216 0.107 0.109 0.028 0.016 0.025
AB 0.456 0.159 0.343 0.077 0.019 0.073
B -0.103 0.115 0.042 0.023 -0.031 0.028
Gender
Male -0.028 0.069 0.006 0.023 0.006 0.02
Primary Renal Diagnosis
Polycystic kidney disease 0.382 0.175 0.011 0.042 -0.067 0.072
Diabetes -0.196 0.175 0.03 0.046 0.004 0.073
Hypertension -0.018 0.174 0.009 0.044 -0.05 0.068
Other diagnosis 0.173 0.17 0.028 0.034 0.027 0.073
Peak Reactive
Antibody -0.007 0.002 -0.002 0.0005 -0.001 0.0005
BMI
Low -0.092 0.397 0.069 0.083 0.122 0.19
Normal -0.036 0.082 0.019 0.022 0.063 0.035
Overweight 0.059 0.086 0.049 0.021 0.045 0.024
Age (in decades) -0.295 0.041 0.015 0.01 0.019 0.009
Table 2.3: Results of application to SRTR data: Cluster Effects
Parameter Estimate SE
θa 0.040 0.017
θb11 0.010 0.008
θb22 0.018 0.009
θb12 0.010 0.007
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From Table 2.2, age at listing, BMI > 30, panel reactive antibody and being
African American demonstrated significant negative effects on the marginal proba-
bility of receiving a deceased donor kidney transplant. Being African American also
seemed to have a significant effect on the timing of receipt of transplant for patients
who eventually receive a transplant. In Table 2.3, we examine the effects of clustering
on the data. The results seem to indicate that, for our data, the clustering of patients
within transplant centers can be sufficiently addressed by including random effect
terms in the probit regression model for the marginal probability of transplantation.
2.6 Discussion
In this chapter we propose a semiparametric random effects model for clustered
competing risks data based on the mixture regression modeling framework. Our
method presents an approach to estimate covariate effects on cumulative incidence
functions of all competing causes simultaneously, while accounting for correlation
of event times across subjects within cluster. To the best of our knowledge, there
are no existing methods to deal with clustered or correlated competing risks data
that allow for joint inference on all cause-specific cumulative incidence functions.
Prominent methodologies focus on a single cause of interest and in doing so are not
able to capture the interplay between competing events. By explicitly addressing the
additivity constraint for cumulative incidence functions our method is able to provide
meaningful predictions of absolute risk of all causes at a specified time and inference
about marginal probabilities. Further, our method provides a quantification of the
effects of clustering both within and across causes.
A potential drawback of our method is that it might require data with longer
follow-up times. Essentially, our method requires sufficient information in the tail
of the event time distribution to be able to distinguish between the marginal model
for the type of event and the conditional model for the timing of an event given the
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type.
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CHAPTER III
Weighted estimators of the complier average
causal effect on restricted mean survival time with
observed instrument-outcome confounders
3.1 Introduction
A major concern in any study lacking randomized treatment assignment is the
potential for confounding of the relationship between the treatment and outcome of
interest. In the absence of randomization, estimation of the causal effect of treatment
generally requires an untestable and often unrealistic assumption regarding the treat-
ment selection mechanism. Specifically, it needs to be assumed that the treatment is
randomly assigned conditional on the observed covariates, i.e., there are no unmea-
sured confounders of the treatment-outcome association. Unmeasured confounding
can be overcome by conducting an instrumental variable (IV) analysis. This requires
the availability of an IV, which is a variable (a) that is associated with the treatment
of interest, (b) that has no direct effect on the outcome except through the treat-
ment of interest and (c) whose association with the treatment and the outcome is not
confounded by any unmeasured confounders. Such a variable, when available, can be
used to identify treatment effects without knowledge of the treatment selection mech-
anism (Imbens and Angrist (1994), Angrist et al. (1996)). Some common examples
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of IVs in the binary treatment setting include physician preferences for treatment
prescription, randomized encouragement to treatment, and treatment assignment in
randomized clinical trials with noncompliance.
With the use of instrumental variable methods in biomedical studies gaining pop-
ularity only recently, there has been very little research into developing methods for
IV analysis of right censored time-to-event data. For the randomized study setting,
Robins and Tsiatsis (1991) developed semiparametric estimators of the treatment
effect under a semiparametric structural accelerated failure time model for the out-
come. Loeys and Goetghebeur (2003) extended the approach proposed by Robins and
Tsiatsis (1991) to a proportional hazards model of treatment effect working with the
restriction that subjects randomized to control have no access to treatment. Baker
(1998) worked with discrete-time survival data and developed an estimator of the dif-
ference in hazards at a specific time between compliers in the treatment and control
groups of a randomized trial. This estimator is analagous to a standard IV estimator
applied to a survival outcome at a specific time but can result in negative estimates
of hazards and can be inefficient in certain situations. Seeking to gain efficiency, Nie
et al. (2011) utilized the mixture structure implied by the latent compliance model to
develop a plug-in non-parametric empirical maximum likelihood estimation approach
for the difference between compliers in the treatment and control groups of a random-
ized trial, with respect to survival probability at a specific time point. However, like
the method proposed by Loeys and Goetghebeur (2003), Nie et al. (2011) requires
that subjects randomized to the control group have no access to treatment. More
recently, Richardson et al. (2016) considered competing risks data and proposed non-
parametric estimators, decomposing the overall causal effect of treatment on survival
probability at a fixed time point into the sum of causal effects on cause-specific cu-
mulative incidence functions. Like the other authors mentioned above, these authors
assume independent censoring.
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A major drawback of all the aforementioned methods and a few others (eg.
Elashoff et al. (2012)), is that they do not take covariates into consideration and
thus do not allow for IV-outcome confounding. As such, these methods are not
suited for causal inference from observational data. Among the methods that do
permit inclusion of covariates, Mark and Robins (1993) considered an accelerated
failure time model for the outcome, Cuzick et al. (2007) considered a proportional
hazards model and Gong (2008) considered parametric survival models. More re-
cently, Tchetgen Tchetgen et al. (2015) proposed a control function approach to
estimate the difference in hazards at a specific time under an additive hazards model
for the outcome. This approach shares some similarity with approaches developed for
continuous instrumental variables in the censored time-to-event data setting which
assume an additive hazards model for the outcome (e.g., Li et al. (2015)). Yu et
al. (2016) extended the work of Cuzick et al. (2007) to the class of semiparametric
linear transformation models which include the proportional hazards model and pro-
portional odds model as special cases.
In this chapter, we develop an estimator for the treatment effect on the re-
stricted mean survival time (RMST) under unmeasured confounding of the treatment-
outcome association using a binary IV analysis. Being a cumulative treatment effect,
the effect of treatment on RMST may be of greater interest than the effect on survival
or hazard at a specific time point, especially in the presence of a treatment effect that
changes over time (Schaubel and Wei (2011)). To the best of our knowledge, only
one other author has studied IV analysis of RMST. Kjaersgaard and Parner (2016)
proposed a pseudo-outcome approach to determine treatment effects on RMST in a
setting with a continuous IV.
Our motivating example inovolves the comparison between peritoneal dialysis
(PD) and haemodialysis (HD), the two most frequently used dialysis modalities, with
respect to 5-year RMST among end stage renal disease (ESRD) patients. While
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kidney transplantation remains is preferred treatment for patients with ESRD, most
patients are placed on dialysis until a transplant is available or as their only therapy.
While many studies have compared the two modalities currently in use, results have
been conflicting with some studies have showing PD to be associated with a survival
advantage initially but no significant difference afterward (Fenton et al. (1997), Jaar
et al. (2005), Heaf et al. (2002), Kumar et al. (2014)) and others showing that
mortality rate is higher in patients receiving PD, especially older patients, than those
receiving HD (Kim et al. (2014), Weinhandl et al. (2010)). A key concerns in most
of the studies of this comparison is strong selection bias, as PD patients tend to be
younger and healthier, and as studies mostly only adjust for observed confounders.
This leads to the question, if unmeasured confounders were accounted for, which dial-
ysis modality would be preferred in terms of patient survival?
In an observational setting, such as ours, the assumption that the instrument of
choice is completely randomly assigned might not be valid. However, the random
assignment requirement may be met after adjusting for a set of observed instrument-
outcome confounders, making the instrument conditionally distributed “as good as
random”. These measured instrument-outcome confounders can be adjusted for by
including them in two stage regression models or through matching. Two stage regres-
sion modeling in the survival setting often requires additional modeling assumptions
(Li et al. (2015), Tchetgen Tchetgen et al. (2015)). Matching, on the other hand,
may be infeasible in the presence of even a moderate number of covariates, as in
our setting. For such situations, some authors (e.g., Frolich (2007)) have proposed
matching using the instrument propensity score, i.e., the conditional probability of
assignment to the instrument group encouraging treatment given covariates. An al-
ternative to matching and regression based estimators are inverse weighting based
estimators with weights based on the estimated instrument propensity score. Previ-
ously, Tan (2007) proposed an inverse probability of instrument weighted (IPIW) IV
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estimator, where subjects in each instrument group are weighted by the inverse of
the conditional probability of assignment to that instrument group. The weights pro-
posed by Tan (2006) are analogous to the traditional inverse probability of treatment
weight (IPTW) (Robins et al. (2000)) used for treatment comparisons in the uncon-
founded setting. In this chapter, we propose to use weights that, as will be shown
later, tend to produce more efficient estimators than matching or IPIW proposed by
Tan (2006). Further, unlike matching based estimators, we are able to derive easily
implementable asymptotic variance estimators for our proposed treatment effect es-
timators and thus do not have to rely on resampling based methods.
In Section 3.2, we begin with a description of the notation and assumptions re-
quired for our method. We then derive the asymptotic properties of our proposed
estimators; proofs of which are provided in the Appendix. In Section 3.3, we evaluate
the performance of our estimators in finite samples. In Section 3.4, we apply our
methods to compare HD and PD modalities using data from the United States Renal
Data System (USRDS). Finally, in Section 3.5, we provide a discussion.
3.2 Methods
3.2.1 Notation
Our data consist of subjects randomized to one of two levels of a binary instru-
mental variable. Henceforth, we refer to these two levels of the IV as encourage-
ment toward the treatment and encouragement towards control. For each subject
i(i = 1, ..., n), the binary IV is denoted by Zi, with Zi = 1 for subjects randomized
to receive encouragement toward treatment and Zi = 0 for subjects randomized to
receive encouragement toward control. While the effect of the randomly assigned
encouragement status may sometimes be of interest, the goal of an IV analysis is to
estimate the causal effect of the treatment actually received.
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To this end, we use Rubin’s potential outcome framework to define quantities of
interest. We first define a vector of potential treatment outcomes for each subject
as Ai
∗ = (Ai(0), Ai(1)), where Ai(0) and Ai(1) denote the treatment that subject i
would have received had they been randomized to receive Zi = 0 and Zi = 1, respec-
tively. Then, under the so-called consistency assumption (Rubin, 2005), the observed
treatment Ai = Ai(0)I(Zi = 0) + Ai(1)I(Zi = 1). Based on the vector of potential
treatment outcomes, subjects can be grouped into four complier classes: subjects
with Ai
∗ = (0, 1) are compliers (i.e., they receive treatment only if encouraged toward
treatment); subjects withAi
∗ = (1, 1) are always takers (i.e., they always receive treat-
ment); subjects with Ai
∗ = (0, 0) are never takers (i.e., they never receive treatment);
and subjects with Ai
∗ = (1, 0) are defiers (i.e., they receive treatment only if en-
couraged toward control and vice-versa). We further define Ti(z, ai(z)), the potential
time-to-event that would be observed if subject i is randomized to Z = z and actually
receives treatment ai(z), for all combinations of (z, ai(z)). In the absence of censoring,
an IV analysis estimates the causal effect of the treatment received on subjects in the
complier class, i.e., an IV analysis estimates δ = E[Ti(1, 1) − Ti(0, 0)|Ai∗ = (0, 1)].
This is commonly referred to as the local average treatment effect (LATE) or the
complier average causal effect (CACE).
Let Ti denote the time-to-event, which is subject to right censoring by Ci. We
let Xi be a vector of observed time-independent covariates that, in the absence of
adjustment, could potentially confound the instrument-outcome relationship. We let
∆i = I(Ti ≤ Ci) be the observed event indicator. The observed data for each sub-
ject i, then consists of {T˜i,∆i,Xi, Ai}, where T˜i = min (Ti, Ci) represents observation
time. The presence of censoring generally implies that the mean survival time is not
identifiable. As such, we propose to measure the causal effect in terms of the RMST.
The RMST at a given time L is defined as the E(min(T, L)), where it is required
that L ≤ τ with τ denoting the maximum observation time. Note that RMST is also
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equal to the area under the survival curve in the interval [0, L].The causal effect of
interest then becomes, δ(L) = E[min(Ti(1, 1), L)−min(Ti(0, 0), L)|Ai∗ = (0, 1)].
3.2.2 Assumptions
To estimate the CACE, we make the following six assumptions:
A1. Stable unit treatment value assumption (SUTVA).
Also called the no interference assumption, SUTVA states that each subject’s
potential outcomes are not affected by the randomly assigned encouragement
status of other subjects in the population. This allows us to consider each
subject’s potential outcomes as a function of only their encouragement status
and treatment.
A2. Independence of instrument. Zi ⊥ Ai(0), Ai(1), Ti(0, 0), Ti(0, 1), Ti(1, 0), Ti(1, 1)|Xi.
This assumption states that the potential outcomes are independent of the ran-
domly assigned encouragement status, conditional on the observed covariates.
Essentially, we are assuming that conditioning on the observed covariate vector,
the IV is independent of unmeasured confounders.
A3. Exclusion Restriction. Ti(0, 1) = Ti(1, 1), Ti(1, 0) = Ti(0, 0)|Xi.
This assumption states that the IV can affect the outcome only by affecting the
treatment received.
A4. Non-zero causal effect of Z on A: E(Ai(1)− Ai(0)) > 0.
The IV, encouragement status, is assumed to have a positive effect on the actual
treatment received.
A5. Monotonicity: Ai(1) ≥ Ai(0).
This asumption says that the potential treatment received under encouragement
toward treatment is greater than or equal to that under encouragement toward
control. This rules out the existence of the defiers class.
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A6. Independent Censoring. Ci ⊥ Ti|Zi,Xi.
Censoring is assumed to be independent of time-to-event given the observed
covariates and encouragement status.
Under assumptions A1-A5 and in the absence of censoring, the CACE can be recov-
ered from observed quantities as:
δ(L) =
E[min(Ti, L)|Zi = 1]− E[min(Ti, L)|Zi = 0]
E[Ai|Zi = 1]− E[Ai|Zi = 0] (3.1)
However, in the presence of censoring, assumption A6 permits the construction of an
inverse probability of censoring weighted estimator of the quantity in the numerator
of equation (3.1).
3.2.3 Weighting
To account for measured confounders of the instrument-outcome relationship, we
re-weight the data using weights based on the instrument propensity score, defined
as,
e(X) = Pr(Z = 1|X). (3.2)
Owing to the balancing property of the propensity score, conditioning on e(X) retains
independence of the IV and unmeasured confounders, and using weights based on
e(X) sufficiently adjusts for confounding due to X. Furthermore, assumptions A2,
A3 and A6 which condition on X, can also be written by conditioning on e(X)
instead.
We propose using two different weights, namely, a matching weight intially studied
by Li et al. (2013), and an overlap weight initially developed by Li et al. (2016). Both
of these weights are based on the instrument propensity score. The matching weight
(MW) was developed as a weighting analogue to paired matching on the propensity
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score and is expressed as,
MW =
min{e(X), (1− e(X))}
Ze(X) + (1− Z)(1− e(X)) . (3.3)
Li et al. (2013) show that, in the unconfounded setting, the estimator of treatment
effect obtained using the MW is asymptotically equivalent to the estimator obtained
from one-to-one paired matching on the propensity score. Essentially, using the MW
then provides a method to make treatment comparisons using all the subjects in the
data and thus provides a more efficient alternative to matching where unmatched
subjects are discarded. Further, unlike matching, the weighting approach leads to
more accurate variance calculation and simpler asymptotic analysis. These appealing
attributes of the MW motivate us to investigate its use for the setting with unmea-
sured confounders. Thus, we develop a MW estimator of the CACE that can be
viewed as a more efficient alternative to the instrument propensity score matching
based estimator.
The overlap weights (OW) were proposed by Li et al. (2016) for the comparison
of binary treatments in the unconfounded setting. The OW are target to estimate the
treatment effect in a sub-population with the most overlap, that is, a sub-population
of subjects who could appear with substantial probability in either treatment group.
The overlap weights belong to a broader class of covariate balancing weights in the
binary treatment setting which includes MW and IPIW. As Li et al. (2016) show,
among this class, the overlap weights based estimator has the minimum asymptotic
variance. Further, as the authors note, the overlap weights are in a sense asymp-
totically equivalent to matching. Specifically, a matching analysis based on exact
matching of subjects on the same discrete design points (or small neighborhood, for
continuous variables) would use weights equivalent to the overlap weights estimated
from a saturated propensity score model with an indicator for each design point.
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Here, we propose using the OW to estimate the CACE, with the weights expressed
as,
OW =
e(X)(1− e(X))
Ze(X) + (1− Z)(1− e(X)) . (3.4)
We compare the proposed weights to the inverse instrument probability weights
(IPIW) proposed by Tan (2006), and expressed as,
IPIW =
1
Ze(X) + (1− Z)(1− e(X)) (3.5)
As mentioned earlier, the IPIW weights seek to achieve covariate balance across in-
strument groups by re-weighting subjects in each group by the probability of being
assigned to the observed instrument group. The IPIW weights may become very large
when the propensity score approaches 0 or 1, leading to biased and highly inefficient
estimates of treatment effect. As will be seen in our simulation studies, the weights
we propose are able to guard against this as they are bounded between 0 and 1.
3.2.4 Estimation
In this section we develop an estimator, δˆ(L), of the CACE on the RMST in
presence of measured time-independent confounders of the instrument-outcome and
instrument-treatment relationship, Xi. We first concentrate on estimating the quan-
tities in the numerator of (3.1).
Let Ni(t) = ∆iI(Ti ≤ t) be the observed event counting process indicator and
Yi(t) = ∆iI(Ti ≥ t) be the observed at-risk process indicator. Further, define IV
level-specific versions dNiz(t) = I(Zi = z)dNi(t) and Yiz(t) = I(Zi = z)Yi(t), where
z ∈ {0, 1}. Then, in the absence of censoring, an estimate of the cumulative hazard
Λz(t) when randomly assigned to IV level Z = z can be obtained using the weighted
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Nelson-Aalen estimator,
Λˆz(t) =
n∑
i=1
t∫
0
wei (βˆ)dNiz(s)∑n
i=1w
e
i (βˆ)Yiz(s)
, (3.6)
where wei (βˆ) are weights based on a model-based estimate of the IV propensity score,
e(Xi). We assume that the IV assignment givenXi follows a logistic regression model
with parameters β, such that:
Pr(Zi = 1|Xi) = logit−1(XTi β).
Here, we do not distinguish between the type of weight as the expression for the
estimator is the same regardless of the type of weight, that is, wei (βˆ) could be equal
to the MW, OW or IPIW.
To adjust for covariate dependent censoring, we weight each subject’s contribution
at time t by the inverse of the probability of being uncensored at time t, i.e., each
subject’s contribution in (3.3) is multiplied by wci (t) = P (Ci ≥ t|Xi)−1. As the true
censoring distribution is unknown in most cases, an estimate wˆci (t) can be obtained
non-parametrically or by fitting separate Cox proportional hazards models to the
censoring distribution at each level of the IV. For example, if the censoring time
for subjects assigned to IV level Z = z is modeled using the following proportional
hazards model λciz(t) = λ0z(t) exp(X
T
i θ0z), then, an estimate for w
c
i (t) when randomly
assigned to IV level Z = z is given by wˆci (t; θˆz) = exp(Λˆ0z(t; θˆz) exp(X
T
i θˆz)). Thus, in
the presence of covariate-dependent censoring, the weighted Nelson-Aalen estimator
of the cumulative hazard Λz(t) is given by
Λˆz(t) =
n∑
i=1
t∫
0
wˆci (s; θˆz)w
e
i (βˆ)dNiz(s)∑n
i=1 wˆ
c
i (s; θˆz)w
e
i (βˆ)Yiz(s)
. (3.7)
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Let µT,z(L) = E[min(Ti, L)|Zi = z] denote the average RMST at IV level Z = z. An
estimator µˆT,z is obtained as:
µˆT,z(L) =
L∫
0
Sˆz(t)dt, (3.8)
where Sˆz(t) = exp(−Λˆz(t)). Thus, an estimate of the numerator in equation (3.1) is
given by µˆT,1(L)− µˆT,0(L).
The denominator in (3.1) is estimated as the difference in the weighted average of
actual treatment received between the two IV levels. Let µA,z = E[Ai|Zi = z], then
an estimate of the denominator in (3.1) is given by:
µˆA,1 − µˆA,0 =
∑n
i=1w
e
i (βˆ)AiI(Zi = 1)∑n
i=1w
e
i (βˆ)I(Zi = 1)
−
∑n
i=1w
e
i (βˆ)AiI(Zi = 0)∑n
i=1w
e
i (βˆ)I(Zi = 0)
. (3.9)
Thus, an estimate of the complier average causal effect in the presence of covariate-
dependent censoring and observed instrument-outcome confounders is given by:
δˆ(L) =
µˆT,1(L)− µˆT,0(L)
µˆA,1 − µˆA,0 . (3.10)
3.2.5 Asymptotic Properties
The following two theorems summarize the asymptotic behavior of our proposed
estimator.
THEOREM 1: Under assumed regularity conditions (a.) to (g.) in Appendix, Λˆz(t) =
Λˆz(t; βˆ) converges almost surely and uniformly to Λz(t) for t ∈ [0, τ ], and n1/2{Λˆz(t)−
Λz(t)} converges asymptotically to a zero mean Gaussian process with covariance func-
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tion σz(s, t) = E{Φiz(s)Φiz(t)}, where
Φiz(t) = Φiz1(t) + Φiz2(t) + Φiz3(t) + Φiz4(t);
Φiz1(t) = {hz(t) + dz(t)}TΩ−1(β0)n−1/2
n∑
i=1
ψi(β0)
Φiz2(t) = {gz(t) + fz(t)}TΩ−1C (θ0z)n−1/2
n∑
i=1
ψCi (θ0z)
Φiz3(t) =
n∑
i=1
t∫
0
qz(s, t)b(s;β0,θ0z)
−1dMCi (s)
Φiz4(t) =
n∑
i=1
t∫
0
wei (β0), w
C
i (s;θ0z)b(s;β0,θ0z)
−1dMiz(s)
dMiz(s) = dNiz(s)− Yiz(s)dΛz(s)
dMCi (s) = dN
C
i (s)− Yi(s)dΛCz (s)
The expressions Ω−1(β0)n−1/2
∑n
i=1ψi(β0) and Ω
−1
C (θ0z)n
−1/2∑n
i=1ψ
C
i (θ0z) rep-
resent the influence functions for the logistic model (for the IV assignment) and Cox
model (for censoring) respectively. Explicit expressions for these influence functions
and for the other parameters above are given in the Appendix. The consistency of
Λˆz(t; βˆ) is proved through the consistency of βˆ and application of the continuous
mapping theorem and the Strong Law of Large Numbers. The proof of asymptotic
normality follows from expressing n1/2{Λˆz(t) − Λz(t)} as a sum of independent and
identically distributed mean zero variates. Multivariate Central Limit theorem can
then be used to show asymptotic normality at a fixed time point, t, while various
empirical process results can be used to establish convergence to a Gaussian process.
We refer to the Appendix for a detailed sketch of the proof which utilizes some of
the ideas in Schaubel and Wei (2011), where, in Theorem 1, the authors establish the
asymptotic properties for the doubly inverse weighted estimator of treatment group-
specific cumulative hazard functions.
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THEOREM 2: Under regularity conditions (a.) - (g.) in Appendix, δˆ(t) =
µˆT,1(t;βˆ)−µˆT,0(t;βˆ)
µˆA,1(βˆ)−µˆA,0(βˆ)
converges almost surely to δ(t) for t ∈ [0, τ ], and n1/2{δˆ(t)−δ(t)} converges asymptoti-
cally to a mean zero Gaussian process with covariance function σδ(s, t) = E{ξi(s)ξi(t)},
where
ξi(t) = ξi1(t) + ξi2(t);
ξi1(t) = Q
TΩ−1(β0)
n∑
i=1
ψi(β0)
ξi2(t) = {µA,1(t)− µA,0(t)}−1
n∑
i=1
Σi(t)
A detailed sketch of the proof with explicit expressions and definitions for the quan-
tities QT and Σi(t) is given in the Appendix. The covariance function is estimated
by replacing the limiting values with their empirical counterparts.
3.3 Simulation Studies
Simulation studies were conducted to assess the finite sample properties of the
proposed CACE estimator and the associated asymptotic standard error estimator.
We also demonstrate the benefits of using an IV analysis method by comparing the
proposed IV analysis methods to a ‘naive’ analysis. In a ‘naive’ analysis, it is as-
sumed that there is no unmeasured confounding. Thus, one proceeds to estimate the
average treatment effect by adjusting only for the observed covariates, as done in the
unconfounded setting. In the unconfounded setting, treatment comparisons can still
be made by using propensity score matching or inverse weighting based methods but
rather than the instrument propensity score, the treatment propensity score, that
is, the probability of receiving the actual treatment is used. For example, to obtain
a matching based estimator of the average treatment effect in the ‘naive’ analysis,
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subjects are matched across treatment groups on the treatment propensity score and
the difference estimates of RMST between treated and untreated subjects is averaged
across matched sets. Similarly, the inverse-weighting based estimator of the treatment
effect is simply equal to the difference in inverse weighted estimates of RMST in the
treatment and untreated groups, using weights based on the treatment propensity
score.
For our simulations, under assumptions A1 − A6 , data were generated for a setting
with two observed instrument-outcome confounders, {X1, X2} and one unmeasured
confounder, Xu. For each subject, X2 was generated from a Bern(0.6) distribution
and X1 and Xu were generated from two separate univariate N(0, 0.5) distributions.
Given covariate values, the level of IV that each subject was randomized to was gen-
erated from the logistic model, Pr(Z = 1) = logit−1(−0.5 + 3X1 + X2). The actual
treatment receipt status was then generated from the logistic model: Pr(A = 1) =
logit−1(−0.5+Z+0.25X1+0.25X2+0.25Xu). Event times T were then generated from
an exponential model with rate λT = 0.01(−2−A−0.5X1+0.5X2−0.25Xu). Censoring
times C were generated from an exponential model with rate λc = 0.01(−λ0−1.5X2),
where λ0 was set to {1, 2.5} to correspond to a high (∼ 47%) and moderate (∼ 25%)
level of censoring. For each censoring scenario, the performance of the estimators was
evaluated at sample sizes n = 500, 1000, 2000. In all scenarios, we were interested in
estimating the complier average causal effect on the RMST at L = 1825 (i.e., 5 years,
if the time scale were in days). The results discussed in this section are based on 1000
Monte Carlo simulations.
Tables 3.1 and 3.2 display a comparison of the three different weighting estimators
and a propensity score matching approach in an IV analysis and a naive analysis at
sample sizes n = 500, 1000 and 2000 in a setting with ∼ 25% censoring. As expected,
a naive analysis that ignored confounding seemed to produce systematically biased
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Table 3.1: Simulation results: Proposed IV estimators and propensity score
matching with ≈ 25% censored before L = 1825 and δ(L) = 499
Naive Analysis IV Analysis
Method
Percent
Bias ESD
Percent
Bias ESD
Relative
MSE ASE CP
n = 500
IPTW / IPIW -53 54 6 436 1.52 476 0.99
MW -53 54 5 301 0.72 334 0.97
OW -53 55 4 309 0.77 340 0.97
Matching -53 60 1 354 1 1 1
n = 1000
IPTW / IPIW -55 40 2 313 1.75 336 0.99
MW -55 40 2 207 0.77 230 0.98
OW -55 40 2 211 0.79 234 0.98
Matching -55 44 -5 236 1 1 1
n = 2000
IPTW / IPIW -55 40 -4 170 1.13 224 0.99
MW -55 40 -2 139 0.75 158 0.98
OW -55 40 -1 141 0.78 161 0.98
Matching -55 44 -10 155 1 1 1
For Naive Analysis
IPTW = {Ae(X) + (1−A)(1− e(X))}−1
MW -MatchingWeight = min{e(X), (1− e(X))}{Ae(X)+(1−A)(1−e(X))}−1
OW - Overlap Weight = e(X)(1− e(X)){Ae(X) + (1−A)(1− e(X))}−1
For IV Analysis
IPIW = {Ze(X) + (1− Z)(1− e(X))}−1
MW -MatchingWeight = min{e(X), (1− e(X))}{Ze(X)+(1−Z)(1−e(X))}−1
OW - Overlap Weight = e(X)(1− e(X)){Ze(X) + (1− Z)(1− e(X))}−1
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Table 3.2: Simulation results: Proposed IV estimators and propensity score
matching with ≈ 25% censored before L = 1825 and δ(L) = 499
Naive Analysis IV Analysis
Method
Percent
Bias ESD
Percent
Bias ESD
Relative
MSE ASE CP
n = 500
IPTW / IPIW -45 71 -5 512 1.14 474 0.97
MW -45 72 -3 411 0.73 376 0.96
OW -44 72 -4 421 0.77 384 0.96
Matching -42 82 11 478 1 1 1
n = 1000
IPTW / IPIW -49 51 -4 395 1.59 343 0.96
MW -49 52 -3 284 0.82 269 0.95
OW -48 52 -3 284 0.82 275 0.95
Matching -47 58 -3 314 1 1 1
n = 2000
IPTW / IPIW -49 51 -3 230 1.1 238 0.97
MW -49 52 0 193 0.77 192 0.96
OW -48 52 0 197 0.8 195 0.95
Matching -47 58 -6 218 1 1 1
For Naive Analysis
IPTW = {Ae(X) + (1−A)(1− e(X))}−1
MW -MatchingWeight = min{e(X), (1− e(X))}{Ae(X)+(1−A)(1−e(X))}−1
OW - Overlap Weight = e(X)(1− e(X)){Ae(X) + (1−A)(1− e(X))}−1
For IV Analysis
IPIW = {Ze(X) + (1− Z)(1− e(X))}−1
MW -MatchingWeight = min{e(X), (1− e(X))}{Ze(X)+(1−Z)(1−e(X))}−1
OW - Overlap Weight = e(X)(1− e(X)){Ze(X) + (1− Z)(1− e(X))}−1
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estimates at all sample sizes. With ∼ 25% of the data being censored, the naive anal-
ysis estimates produced estimates that had a relative bias of 53 − 55%. At a higher
censoring rate of ∼ 47%, the relative bias for the naive analysis estimates ranged from
42− 50%.
For the IV analysis, in terms of bias, the performance of the inverse weighted esti-
mators seemed comparable to that of the propensity score based matching estimator.
The proposed MW and OW estimators, however, outperformed the matching based
estimator with respect to efficiency, measured in terms of mean squared error (MSE),
at all sample sizes and all levels of censoring. The OW and MW based estimators
had a MSE ranging from 0.7 - 0.8 times of that of the matching based estimators.
The IPIW weights, on the other hand, were less efficient than matching with relative
MSE ranging from 1.1 - 1.6. The asymptotic standard error estimators approximated
the true standard deviation well and, correspondingly provided confidence intervals
with appropriate coverage probabilities. The proposed asymptotic variance estimator
provided 95% confidence intervals that covered the true parameter with probability
97% - 99% when ∼ 25% of the data were censored and with probability 95% - 97%
when ∼ 47% of the data were censored.
3.4 Application
We applied our methods compare HD and PD modalities for end stage renal
disease (ESRD) patients using data from the United States Renal Data System (US-
RDS). Previous studies of this question have yielded conflicting results providing no
conclusive evidence for or against the use of PD. This suggests that an IV analysis
might be in order to adequately address unmeasured treatment-outcome confounding
and shed some valuable insight on the problem.
We conducted an IV analysis to estimate the effect of dialysis modality on the
restricted mean survival at 5 years (L = 1825 days) since ESRD incidence. Our
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study population consisted of incident dialysis patients initiating dialysis between
01/01/2009 and 12/31/2014. A potential instrument is the dialysis facility-level vari-
ation in PD usage, defined as the facility-specific proportion of patients initiating
dialysis with PD. We used a dichotomized version of this instrument, with patients
in facilities with PD usage above the national average of PD usage defined as be-
ing randomized to receiving the instrument of encouragement toward PD. Owing
to the nature of our analysis we excluded small dialysis facilities defined as having
< 10 PD patients and < 50 patients in total. After this step, our study cohort had
164,837 patients distributed across 929 dialysis facilities in the United States. To
avoid introducing patient-level confounding between the instrument and unmeasured
confounders, historical data from 2006-08 was used to determine PD usage. The mean
PD usage rate within facility varied from 1.8% to 54.6% with a mean of 14.5% and
median of 12.5%. The correlation between facility-level mean PD usage in 2006-08
and 2009-14 was 0.57, and the dichotomized PD encouragement status was signifi-
cantly associated (β = 0.1, p < 0.0001) with individual PD uasge in a model adjusting
for available patient-level covariates, suggesting potential for a good instrument.
Table 3.3 presents a comparison of patients initiating dialysis on PD and HD with
respect to age, comorbidities and primary renal diagnosis. On average, PD patients
were indeed 5 years younger and healthier in terms of having fewer comorbidities than
HD patients. While these patient-level factors are observed and can be adjusted for in
a regression analysis, it is plausible that other unmeasured patient-level confounders
might influence both the choice of dialysis modality and survival, thus, necessitating
an IV analysis. The likelihood of unmeasured confounding seems greater knowing
that every available risk factor in Table 3.3 is more prevalent for HD than PD pa-
tients.
Based on historical evidence as important predictors, we included the follow-
ing patient-level covariates in the logistic regression model for estimating the instru-
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Table 3.3: Analysis of USRDS Data: Description of Study Cohort by Dialysis Modal-
ity
Covariate Haemodialysis
Peritoneal
Dialysis
Standardized
Difference
Percent Died 53 36 -36.3
Age (Years) 63.6 58.1 -36.5
Primary Renal Diagnosis
Diabetes 46 43 -5.9
Hypertension 28 26 -4.6
Glomerulonephritis 8 15 22.3
Other 17 15 -5.5
Comorbidities
Alcohol Use 2 1 -11.6
ASHD 21 13 -21.3
Cancer 8 5 -11.9
CHF 33 16 -39.5
COPD 10 4 -22.4
CVA 10 6 -13.7
Diabetes 11 7 -12.1
Drug Use 1 0 -10.7
PVD 14 9 -17.4
Tobacco Use 7 6 -2.9
Table 3.4: Analysis of USRDS Data: Results from IV and Naive analysis
Method IV Analysis Naive Analysis
Method Estimate 95% Interval Estimate 95% Interval
IPIW 87.5 (17.8 , 157.1) 118.4 (107.5 , 129.1)
MW 88.5 (18.1 , 158.8) 102.0 (88.5 , 115.5)
OW 87.5 (17.9 , 157.0) 118.2 (108.9 , 127.6)
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ment propensity score: year of ESRD incidence, age at dialysis initiation, gender,
race, ethnicity (Hispanic or not), primary renal diagnosis (glomerulonephritis (GN)
diabetes, hypertension, and others), and binary comorbidity indicators for the pres-
ence of cancer, diabetes, athlero-sclerotic heart disease (ASHD), congestive heart fail-
ure (CHF), chronic obstructive pulmonary disease (COPD), cerebrovascular accident
(CVA), peripheral vascular disease (PVD), elicit drug use, tobacco use, and alcohol
consumption. The censoring distribution in each instrument-level was estimated us-
ing separately fitted Cox hazards regression models including all the aforementioned
patient-level covariates. The estimated propensity score and censoring probabilities
was then used to construct the weighted estimator in equation (3.7).
In Table 3.4 we present the results from the IV analysis and the corresponding
‘naive’ analysis for each of the proposed inverse-weighting based estimators. For the
‘naive’ analysis, we ignored the presence of unmeasured confounders of the treatment-
outcome relationship, i.e., we estimated the causal effect as the difference in inverse
weighted estimates of RMST in the treatment and control groups, using weights based
on the treatment propensity score. Both the IV and naive analysis showed the use of
PD to be beneficial. The IV analysis indicated that initiating dialysis using PD may
lead to a gain in 5-year RMST of nearly 3 months.
3.5 Discussion
In this chapter, we develop a weighted estimator of the complier average causal
effect on the restricted mean survival time. The proposed method addresses un-
measured confounding of the treatment-outcome relationship in the censored time-
to-event setting. A unique feature of our approach it that it accomodates observed
instrument-outcome confounding, such that one only needs to assume that the instru-
ment is randomly assigned conditional on some observed covariates. This makes the
proposed estimator particularly suited for causal inference from observational studies.
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The weights we propose to use, namely the matching weight and the overlap weight
tend to outperform the IPIW proposed by Tan (2006) and propensity score matching
in terms of MSE even in the presence of moderate variability in instrument propensity
score. This was seen to be the case even when we explored using a variance stabi-
lized version of IPIW weights (results not shown here), with simulation results being
nearly identical to that presented here. This is mainly because, unlike the IPIW,
both the MW and OW are bounded between 0 and 1 and are thus less sensitive to ex-
treme weights. Further, an advantage of using the proposed weighted estimators over
matching is the availability of easily implementable asymptotic variance estimators
which are derived in this chapter. Future research could concentrate on improving
these estimators further by developing a doubly robust version of the MW and OW
based estimators of the CACE.
To the best of our knowledge, this is the first study of a binary IV analysis of
RMST. The only other study of an IV analysis method for estimating causal effects
on the RMST (Kjaersgaard and Parner (2016)) was in the context of a contionuous
IV and used a pseudo-observation appraoch. As Kjaersgaard and Parner (2016) point
out, a major limitation of the pseudo-observation approach is that censoring is re-
quired to be independent of covariates and instrument. In comparison, the proposed
method only requires the assumption that censoring and survival times are indepen-
dent conditional on covariates and instrument. Future research could concentrate
on developing methods that further relax this assumption by allowing censoring to
depend on treatment.
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CHAPTER IV
Instrumental variable estimators of exposure
effects for competing risks data
4.1 Introduction
With the issue of unmeasured confounding arising in many clinical investigations
based on observational data, instrumental variable (IV) analysis methods have been
gaining in popularity in biomedical research. As the name suggests, these methods
exploit the availability of an IV, a variable that is (a) associated with the exposure
of interest, (b) has no direct effect on the outcome except through the exposure of
interest and (c) is not subject to any unmeasured confounding itself. Such methods
seek to overcome unmeasured confounding of the exposure-outcome association. Es-
sentially, the availability of an IV permits the identification of exposure or treatmet
effects without knowledge of the treatment selection mechanism (Imbens and Angrist
(1994), Angrist et al. (1996)).
With an origination in econometrics, IV analysis methods have been widely used
in empirical economic research, but have only recently made their way to biomedical
studies. Consequently, while IV estimation of exposure effects is well established for
continuous and binary outcomes, there has been little research into developing meth-
ods for IV analysis of censored time-to-event data. In one of the first methodological
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investigations in this area, Robins and Tsiatis (1991) developed semiparametric esti-
mators of the treatment effect under a semiparametric structural accelerated failure
time model for the outcome in the randomized study setting, that is, a setting with a
binary exposure and no exogenous covariates. The authors required that all censoring
be administrative or fixed at a certain known time point. Loeys and Goethburger
(2003) extended the approach proposed by Robins and Tsiatsis to a proportional
hazards model of the treatment effect, under independent censoring. Other notable
studies of IV methods for censored time-to-event data in the randomized setting, in-
clude studies by Baker (1998), Nie et al. (2011), Elashoff et al. (2012). More recently,
Richardson et al. (2016) proposed non-parametric treatment effect estimators in the
competing risks setting, decomposing the overall causal effect of treatment on survival
probability at a fixed time point into the sum of causal effects on the cause-specific
cumulative incidence functions. Other studies (e.g., Mark and Robins (1993), Cuzick
et al. (2007), Frolich (2007)) have proposed methods to control for exogenous covari-
ates in the binary exposure setting.
For a continuous exposure, and in the presence of exogenous covariates, Li et
al. (2015) proposed a two stage least squares (2SLS) approach to estimate the ef-
fect of exposure assuming an additive hazards model for the outcome. Chan (2015)
subsequently showed that for the additive hazards model, exposure-dependent cen-
soring could be accommodated using a control function or two stage residual inclusion
(2SRI) approach for estimation. This was further elaborated on by Tchetgen Tch-
etgen (2015), who also considered binary exposures. Kjaersgaard and Parner (2016)
proposed a pseudo-observation approach which requires censoring to be independent
of covariates and instrument. Zheng et al. (2017) extended the method proposed by
Li et al. (2015) to the competing risk setting by assuming an additive subdistribu-
tion hazards model for the cause of interest. Like Li et al. (2015), the authors also
proposed to use a 2SLS approach to estimate the exposure effect, and required that
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censoring be independent of exposure.
In this chapter, we develop an IV analysis method to estimate the effect of an
exposure of interest on the cumulative incidence functions (CIFs) in the competing
risks setting. Competing risks data are encountered in biomedical studies when sub-
jects are subject to failure from many distinct causes or events. Unlike the method
proposed by Zheng et al. (2017), which also address competing risks but focus on
a single primary cause of interest, the method developed in this chapter permits si-
multaneous inference of the exposure effect on all competing causes. Our work here
is specifically motivated by the comparison between peritoneal dialysis (PD) and
haemodialysis (HD), the two most frequently used dialysis modalities, with respect
to cardiovascular (CVD) and non-cardiovascular (non-CVD) mortality among end
stage renal disease (ESRD) patients in the 5 years following initiation of dialysis.
Thus, in our case, the two different competing events are: cardiovascular death and
non-cardiovascular death. While many studies have compared the two modalities
currently in use with respect to overall survival, very few studies have examined the
difference in cause-specific mortality rates across modalities. Some registry based
studies seem to suggest that PD use may be associated with an increased risk in
myocardial infarction (Johnson et al. (2009), Kim et al. (2015)), contributing to a
higher rate of CVD death in PD patients. However, as PD patients tend to be younger
and healthier, and as studies mostly only adjust for observed confounders, selection
bias is a concern for most of the observational studies of comparison between PD and
HD patients. Thus, here, we seek to answer the question, if unmeasured confounders
were accounted for, which dialysis modality is more successful in terms of CVD and
non-CVD mortality?
Competing risks data are often analyzed through modeling of cause-specific haz-
ards or the instantaneous risk of an event (Prentice and Kalbfleisch, 1978). Let T
denote the time to first event and  ∈ {1, ..., K} denote the cause or type of failure,
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with K being the number of distinct causes. Then, the cause-specific hazard for an
event  = k at time t is λk(t) = lim∆t→0 Pr(t ≤ T < T + ∆t,  = k)/(∆t). More re-
cent wrk has focused on modeling another identifiable quantity from competing risks
data, the subdistribution or cumulative incidence function for the kth cause-specific
event: Fk(t) = Pr(T ≤ t,  = k). The cumulative incidence function measures the
absolute event-specific risk and presents a scientifically relevant alternative to the
cause-specific hazard function. Many techniques have been proposed for direct mod-
eling of covariate effects on the subdistributuion function. For example, Fine and
Gray (1999) proposed a Cox proportional hazards model for the subdistribution haz-
ards, Sun et al. (2006) explored an additive hazards model, Andersen et al. (2003)
and Klein and Anderson (2005) proposed a pseudo-value based approach, Jeong and
Fine (2007) proposed parametric regression of the cumulative incidence functions, and
recently, Scheike et al. (2008) proposed direct binomial regression of the cumulative
incidence function through a flexible semiparametric model where some covariates
have time-varying effects and others have constant effects.
The aforementioned methods focus on estimating covariate effects on the cumu-
lative incidence function of a primary cause of interest only, allowing an arbitrary
structure for other causes. Investigators may often be interested in a simultane-
ous analysis of the different cause-specific events. In such cases, while using any of
the aforementioned methods, the model for each cause has to be fitted separately.
However, fitting the models repeatedly, for each cause, may not be appropriate as
these models may not hold simultaneously. Recently, Mao and Lin (2016) devel-
oped a method based on semi-parametric transformation models that permits joint
inference on all competing events. However, none of the methods mentioned above
explicitly address the additivity constraint for the cumulative incidence functions,∑
k Pr( = k) = 1, that is, the constraint that a subject must eventually fail from
one and only one of the many distinct causes.
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The additivity constraint can be explicitly incorporated using a mixture regression
modeling framework. Notable studies of the mixture regression modeling framework
include Larson and Dinse (1985), Maller and Zhou (2002), Lu and Peng (2008) and
Choi and Huang (2014). In this approach, the model for cumulative incidence func-
tions is decomposed into a model for failure time conditional on the cause of failure,
Pr(T ≤ t| = k), and a model for the marginal probability of the cause of failure,
Pr( = k). In this chapter, we develop IV-estimators for competing risks data under a
semiparametric mixture component model on the cumulative incidence functions. In
essence, we develop a method to identify exposure effects on the cumulative incidence
functions of all causes simultaneously in the presence of unmeasured confounding.
Our method is able to accommodate exposure dependent censoring and control for
observed instrument outcome covariates.
In Section 4.2, we begin with a description of the semiparametric mixture re-
gression model and lay out the assumptions required for our method. In Section
4.3, we describe the estimation procedure and the resampling method used to obtain
asymptotic variance estimators. In Section 4.4, we evaluate the performance of our
estimators in finite samples.
4.2 Setup and Model
Consider a setting where subjects can fail from one and only one of K causes with
 ∈ {1, ..., K} denoting the cause of failure. Let T and C denote the failure time and
the censoring time, respectively, with T˜ = min(T,C) denoting the observed event
time. Further, let ∆ = I(T ≤ C) be the observation indicator, so that ˜ = ∆ is the
observed event indicator. We are interested in estimating the effect of an exposure Xe
on the cumulative incidence functions for each competing risk. However, we assume
that this effect is subject to confounding by an unobserved covariate Xu which is
correlated with Xe. We also allow for the presence of some observed subject-specific
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time-independent covariates Xo.
As noted earlier, we seek to develop a method that permits simultaneous infer-
ence on all cause-specific cumulative incidence functions. To this end, using the
mixture model representation for competing risks we decompose the model for cause-
specific cumulative incidence functions into a model for the cause of failure, , given
(Xe, Xu,Xo), and a model for conditional cumulative incidence function Pr(T ≤ t| =
k,Xe, Xu,Xo). By doing so, we ensure that the additivity constraint for cumulative
incidence functions is met.
For ease of representation and without loss of generality, we write down our mod-
els and describe our estimation procedure for K = 2, such that  ∈ {1, 2}. We
assume the following probit regression model for the marginal distribution of  given
(Xe, Xu,Xo):
I{ = 1|Xe, Xu,Xo} = I{γ0 + γToXo + γeXe + ξ(Xu) > 0}, (4.1)
where ξ(Xu) is a mean-zero residual error dependent on the unobserved confounder
Xu but independent of Xo. We further assume the following additive hazards model
for conditional cumulative incidence functions:
Pr(T ≤ t| = k,Xe, Xu,Xo) = 1−exp{−ηk(t)−βTkoXot+βkeXet+bk(Xu)t}, k ∈ {1, 2},
(4.2)
where bk(Xu) is dependent on Xu. This leads us to the following model for the
cumulative incidence function of cause 1:
F1(t|Xe, Xu,Xo) =
E[I{γ0 +γToXo+γeXe+ξ(Xu) > 0}]{1−exp{−η1(t)−βT1oXot+β1eXet+b1(Xu)t}},
(4.3)
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and the following model for the cumulative incidence function of cause 2:
F2(t|Xe, Xu,Xo) =
E[1−I{γ0+γToXo+γeXe+ξ(Xu) > 0}]{1−exp{−η2(t)−βT2oXot+β2eXet+b2(Xu)t}}.
(4.4)
As Xu is not observed and as a confounder correlated with Xe, naively fitting
models (4.3) and (4.4) using observed data will lead to inconsistent estimates of
the effect of the endogenous variable on the cause-specific cumulative incidence. To
this end, we propose an instrumental variable approach that enables the consistent
estimation of γe, β1e, β2e. For this, we assume the availability of an instrumental
variable XI , such that:
Xe = αc +α
T
oXo + αIXI + ν, (4.5)
where αc,α
T
o and αI are coefficients for a constant intercept term, the observed or
exogenous covariates and the instrumental variable, respectively in a linear model
generating the endogenous variableXe. The above model also contains a residual error
term, ν, that depends on the unobserved confounder Xu, so that Cov(Xu, ν|XI ,Xo) 6=
0. This induces confounding of the exposure-outcome relationship.
Given model (4.5), consistent estimation of γe, β1e, β2e is possible using the control
function approach assuming the following standard IV conditions:
A1. ν is a mean zero normal random variable with E(ν|XI ,Xo) = 0, that is, ν is
uncorrelated with XI ,Xo.
A2. αI 6= 0 in model (4.5)
A3. XI is uncorrelated with (Xu, T, ) given Xe
A4. Xo is uncorrelated with Xu
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A5. ξ(Xu), b1(Xu), b2(Xu) are mean zero normal random variables such that:
(a) ξ(Xu) = γνν + eξ, where eξ ∼ N(0, σ2ξ )
(b) b1(Xu) = β1νν + eb1 , where eb1 ∼ N(0, σ2b1)
(c) b2(Xu) = β2νν + eb2 , where eb2 ∼ N(0, σ2b2),
where eξ, eb1 and eb2 are independent and normally distributed residual errors
that are uncorrelated with ν and XI ,Xo.
A6. C ⊥ T |Xe, XIXo.
Assumption A1 states that the residual error ν in model (4.5) is uncorrelated with
the observed covariates and the instrumental variable implying that there is no un-
observed confounding of the effect of XI and Xe. Further, A1 implies that model
(4.5) can be fitted using ordinary least squares regression using XI ,Xo as covariates.
Assumption A2 and A3 are standard IV conditions that specify that an instrumental
variable must have a non-zero effect on the exposure and must only affect the outcome
through the exposure variable. Assumption A4 emphasizes that Xo are exogenous
variables independent of Xu. Assumption A5 relates the residual terms in models
(4.2), (4.3) and (4.4) to the residual term in model (4.5). This relation allows the use
of a control function or two-stage residual inclusion approach to consistently estimate
the parameters in these models. To see this, consider the model for the CIF of cause
1 given (Xe,Xo, Xu). Taking expectation over the distribution of observed variables,
i.e., with respect to (Xu|Xe, XI ,Xo), we have:
F1(t|Xe, XI ,Xo) = E{F1(t|Xe, Xu,Xo)|Xe, XI ,Xo}
= E{I{γ0 + γToXo + γeXe + ξ(Xu) > 0}
{1− exp[−η1(t)− βT1oXot+ β1eXet+ b1(Xu)t]}|Xe, XI ,Xo}
= E{I{γ0 + γToXo + γeXe + γνν + eξ > 0}
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{1− exp[−η1(t)− βT1oXot+ β1eXet+ β1ννt+ eb1t]}|Xe, XI ,Xo}
=

∞∫
−∞
I{γ0 + γToXo + γeXe + γνν + eξ > 0}dF (eξ)

∞∫
−∞
{1− exp[−η1(t)− βT1oXot+ β1eXet+ β1ννt+ eb1t]}dF (eb1)

= Φ{γ∗0 + γ∗To Xo + γ∗eXe + γ∗νν}
{1− exp[−H1(t)− βT1oXot+ β1eXet+ β1ννt]}
The second and third equality above follow from assumption A5. In the last equality,
we write H1(t) = η1(t)+ log(Eσ2b1
[exp(−eb1t)] and γ∗ = γ/
√
1− ρ2ξ,ν , where ρξ,ν is the
correlation between ξ(Xu) and ν. More generally, we can write the model for cause
k CIF given (Xe, XI , Xo) as:
F1(t|Xe, XI ,Xo) =
Φ{γ∗0 + γ∗To Xo + γ∗eXe + γ∗νν}{1− exp[−Hk(t)− βTkoXot+ βkeXet+ βkννt]} (4.6)
Intuitively, the residual ν can be thought of as capturing any variation in the distribu-
tion of (T, ) that is attributable to unobserved correlates of Xe. As these unobserved
correlates must include all confounders of the relationship between (T, ) and Xe,
ν can be used as a proxy for the unobserved confounders. For this reason, in the
above parametrization of the cause-specific CIFs, the terms γ∗νν and βkνν are re-
ferred to as control functions, similar to the control functions used in IV estimation
of linear and non-linear models. As ν is not observed, for estimation, we use a con-
sistent estimate obtained from an OLS fit of model (4.5) instead, that is, we use
νˆ = Xe − αˆ0 + αˆoXo − αˆIXI while estimating parameters in model (4.6). Thus, pa-
rameters in model (4.6) is estimated through a ‘two-stage residual inclusion’ (2SRI)
procedure.
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Note that by estimating parameters in model (4.6) we are able to recover (γ0,γo, γe)
up to a multiplicative constant; that is, we identify (γ∗0 ,γ
∗
o , γ
∗
e ). However, if ξ(Xu) is
assumed to be a realization of standard normal random variable, i.e., V ar(ξ(Xu)) = 1,
then the parameter ρξ,ν is identified using an estimate of V ar(ν) from the first stage
OLS regression. Subsequently parameters (γ0,γo, γe) are identified exactly.
The independent censoring assumption A6 required to accommodate right cen-
sored data, is weaker than that used by Li et al. (2015), Zheng et al. (2017) and
other papers which use a two-stage least squares (2SLS) approach to IV analysis of
censored time-to-event data. As demonstrated by Chan (2015), the 2SRI or con-
trol function approach can accommodate censoring that depends on the endogenous
variable Xe whereas 2SLS approaches require that censoring be independent of Xe.
4.3 Inference
4.3.1 Estimation
Assuming that the study contains n subjects, we note that the observed data for
each subject i, i ∈ {1, ..., n}, consists of {Xei, XIi,Xoi, T˜i, ˜i}. In the first stage of our
estimation procedure we regress Xei on (XIi,Xoi). We use OLS to obtain parameter
estimates (αˆ0, αˆo, αˆI) for model (4.5). Using these estimates and the observed Xei,
we estimate the subject-specific residuals in model (4.5) as νˆi = Xei − αˆ0 + αˆoXoi −
αˆIXIi. These νˆi are used instead of ν as predictors in model (4.6). Thus, the second
stage of our estimation procedure involves estimating parameters of model (4.6) with
predictors (Xoi, Xei, νˆi).
To describe the estimation of model (4.6), we introduce some additional notation.
For ease of presentation, we use the following vector notation for the predictors:
Xi = {Xoi, Xei, νˆi} and Wi = {1,Xoi, Xei, νˆi}. The corresponding parameters are
denoted by β = {β0,βo, βe, βν} and γ∗ = {γ∗0 ,γ∗o , γ∗e , γ∗ν}. Using this notation, we
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estimate the following models for cause-specific CIFs:
Fik(t|Xe, XI ,Xo) = Φ{(−1)kγ∗TWi}{1− exp[−Hk(t)− βTkXit]}. (4.7)
Let Nik = I(Ti ≤ t, i = k) be the counting process indicator for cause k and let
Gi(t) = Pr(Ci > t|Xi), then observe that, under conditional independence between
Ci and (Ti, i), we have:
E
{
∆iNik(t)
Gi(t)
}
= E
[
E
{
∆iNik(t)
Gi(t)
|Ti, i
}]
= E(Nik(t)) = Fik(t),
where we condition on the predictors {Xi,Wi}. Scheike et al. (2008) proposed to
estimate parameters for a semiparametric regression model for the cumulative in-
cidence functions by solving estimating equations based on the weighted response
∆iNik(t)/Gi(t). As Gi(t) is usually not known, it could be substituted with an esti-
mate Gˆi(t) obtained from either a non-parametric Kaplan-Meier estimator of the cen-
soring distribution or an estimator based on a regression model, like the Cox propor-
tional hazards model, relating the censoring distribution to covariates. LetDHk(t)(t) =
∂F
Hk(t),βk
ik (t)/∂Hk(t) and Dβk(t) = ∂F
Hk(t),βk
ik (t)/∂βk(t). If Φ{(−1)kγ∗TWi} were
known, the parameters {Hk(t),βk} in (4.7) can be estimated using the following
estimating functions:
UHk(t)(t,Hk(t),βk) =
n∑
i=1
DHk(t)
{
∆iNik(t)
Gˆi(t)
− Fik(t)
}
(4.8)
Uβk(τ,Hk(t),βk) =
n∑
i=1
τ∫
0
Dβk(t)
{
∆iNik(t)
Gˆi(t)
− Fik(t)
}
. (4.9)
However, Φ{(−1)kγ∗TWi} is unknown and depends on the unknown parameter vector
γ∗. To estimate γ∗, we propose another set of estimating equations motivated by
examining the conditional probability that i = k. Note that i is not observed
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for all subjects. In the case that a subject is censored, i.e., when ˜i, and censoring
occurs at time T˜i = t, the probability of i = 1 conditional on T ≥ t is denoted by
gik(t;γ
∗,βk, Hk(t),Wi,Xi), where
gik(t;γ
∗,βk, Hk(t),Wi,Xi) = Pr( = k|Ti > t,Wi,βk, Hk(t))
=
Φ{(−1)kγ∗TWi} exp{−Hk(t)− βTkXit}∑2
k=1 Φ{(−1)kγ∗TWi} exp{−Hk(t)− βTkXit}
.
It follows that,
Pr(i = k|˜i, T˜i = t,Wi,Xi) = E[I(˜i = k) + I(˜i = 0)gik(t;γ,βk, Hk(t),Wi,Xi)].
This leads us to the following estimating function for γ:
Uγ∗ =
n∑
i=1
Wi{I(˜i = k) + I(˜i = 0)gik(t;γ∗,βk, Hk(t),Wi,Xi)− Φ{(−1)kγ∗TWi}}.
(4.10)
Thus, the regression parameters of the marginal model can be estimated by starting
with arbitrary initial values and solving the above estimating equations (4.8), (4.9)
and (4.10) using an iterative algorithm until a pre-specified convergence criterion is
satisfied. Upon convergence, we obtain estimators of γ∗,βk, Hk, denoted by γˆ∗, βˆk, Hˆk
respectively.
As noted earlier, in model (4.7), γ∗ = γ/
√
1− ρξ,ν . For a probit outcome model,
under the assumption that V ar(ξ(Xu)) = 1, we have γν = ρξ,ν/σν , where σν is
the standard deviation of ν. An estimate of the standard deviation of ν, σˆν can
be obtained from the first stage OLS fit of model (4.5). The estimated quantities
σˆν and γˆ
∗
ν can then be used to obtain an estimate of ρξ,ν using the relation γ
∗
ν =
(ρξ,ν/σν)/
√
1− ρξ,ν . Thus, the parameters γ = {γ0,γo, γe, γν} are identified as both
γˆ∗ν and the residual variance of the so-called selection model (4.5), σ
2
ν , are identified.
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4.3.2 Variance Estimation using perturbation resampling
To estimate the variance and to construct confidence intervals for our proposed
estimators, we use a perturbation-based resampling method. We apply perturbing
random variables directly to the contributions of each subject. In the first stage, this
translates to fitting a weighted least squares regression model to the data with subject-
specific weights set equal to the value of perturbing random variables. In the second
stage, the perturbing random variables are applied directly to the estimating functions
at the subject-level to approximate the distribution of the estimators. Specifically,
let {ωi, i = 1, ..., n} be n independent realizations of a positive random variable ω
from a known distribution with unit mean and unit variance. Fixing the data at their
observed values, perturbed estimators {α˜0, α˜o, α˜e} are obtained by fitting a WLS
regression with subject-sepcific weights ωi. These parameter estimates are then used
to estimate ν˜, a perturbed version of νˆ. Using ν˜ and with the remaining data fixed at
their observed values, perturbed estimators of parameters in model (4.7) are obtained
as the solution to the following perturbed estimating functions:
U˜Hk(t)(t,Hk(t),βk) =
n∑
i=1
ωiDHk(t)
{
∆iNik(t)
G˜i(t)
− Fik(t)
}
(4.11)
U˜βk(τ,Hk(t),βk) =
n∑
i=1
ωi
τ∫
0
Dβk(t)
{
∆iNik(t)
G˜i(t)
− Fik(t)
}
(4.12)
U˜γ∗ =
n∑
i=1
ωiWi{I(˜i = k) + I(˜i = 0)gik(t;γ,βk, Hk(t),Wi,Xi)−Φ{(−1)kγ∗TWi}},
(4.13)
where G˜ is the perturbed version of Gˆ, an estimator of the censoring distribution with
weights {ωi, i = 1, ..., n}. The above perturbed estimating equations (4.11)-(4.13)
are solved using the same procedures used to solve their unperturbed counterparts,
estimating equations (4.8)-(4.10), to obtain estimators {ν˜, γ˜, β˜k, H˜k}. By repeatedly
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generating {ωi, i = 1, ..., n}, say M times, we can obtain a large number of realizations
of the perturbed estimators, say - {ν˜(m), γ˜(m), β˜(m)k , H˜(m)k ,m = 1, ....,M}.
It can be shown that the unconditional distribution of estimates {νˆ, γˆ, βˆk, Hˆk} can
be approximated by the conditional distribution of the perturbed estimates given the
observed data (van der Vaart and Wellner, 1996). Thus, the variance and confidence
intervals of estimates {νˆ, γˆ, βˆk, Hˆk} are estimated based on the empirical distribution
of {ν˜, γ˜(m), β˜(m)k , H˜(m)k ,m = 1, ....,M}.
4.4 Simulation Studies
Simulation studies were conducted to assess the finite sample properties of the
proposed method. In the first simulation study, the performance of the proposed
method was examined in a setting with a continuous instrumental variable and in-
dpendent censoring. To do so, under assumptions A1 − A6 , data for K = 2 com-
peting risks were generated for a setting with one observed exogenous covariate, Xo,
generated from a Bern(0.5) distribution, and one instrumental variable XI , gen-
erated from a N(0.25, 1) distribution. Subsequently, the exposure or endogenous
variable was generated from the following linear model: Xe = 0.5XI + ν, where
ν ∼ N(0, 0.5), represented the influence of an unmeasured confounder, say Xu, on
the exposure. The residual error terms correlated with the unmeasured confounder
in models (4.3) and (4.4) were then generated from the following three linear models:
(i) ξ(Xu) = ν + eξ, where eξ ∼ N(0, 0.1), (ii) b1(Xu) = ν + eb1 , where eb1 ∼ N(0, 0.1)
and (iii) b2(Xu) = ν+ eb2 , where eb2 ∼ N(0, 0.75). Given the generated residual error
terms, the exogenous covariate and exposure values, a cause and time of failure were
generated from models (4.3) and (4.4) for each subject with the parameter values set
to {γ0, γo, γe} = {−0.5, 0.5, 0.5}, {β1o, β1e} = {0.5, 0.5}, {β2o, β2e} = {0.5, 0.5} and
η1(t) = η2(t) = t + 1.5t
2. Finally, a censoring time for each subject was generated
from a Unif(0.5, 1.25) distribution.
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Table 4.1: Simulation results comparing proposed IV method to a bench-
mark method and naive regression method at different sample sizes under
independent censoring (∼ 16%)
Benchmark Naive Method Proposed IV Method
Parameter Bias ESD Bias ESD Bias ESD ASE CP
n = 250
γe 0.018 0.223 0.583 0.182 0.016 0.222 0.282 0.990
β1e -0.038 0.726 0.408 0.546 -0.017 0.667 0.710 0.947
β2e -0.037 0.297 0.412 0.209 -0.043 0.288 0.295 0.938
n = 500
γe 0.018 0.143 0.507 0.138 0.019 0.161 0.181 0.980
β1e -0.023 0.479 0.430 0.376 -0.023 0.483 0.479 0.940
β2e -0.041 0.197 0.403 0.140 -0.041 0.202 0.199 0.944
n = 1000
γe 0.007 0.098 0.506 0.091 0.009 0.113 0.123 0.970
β1e -0.023 0.319 0.435 0.258 -0.022 0.322 0.332 0.940
β2e -0.029 0.135 0.403 0.100 -0.028 0.140 0.136 0.930
Bias, Empirical Bias of Estimates; ESD, sample standard deviation; ASE, mean of esti-
mated standard error via resampling method; CP, empirical coverage probability of 95%
interval
Simulation results at sample sizes n = 250, 500 and 1000 are presented in Table 4.1.
The proposed method was compared to a benchmark method, wherein the true value
of ν was used while estimating the parameters and a naive method wherein a model
using only the observed covariates Xo and Xe was fit to the data. As shown in Table
4.1, ignoring unmeasured confounding, as done in the naive method, seemed to lead
to highly biased estimates of the exposure effect. The proposed IV method, on the
other hand, did almost as well as the benchmark method with respect to bias and
empirical stnadard deviation. The proposed resampling-based standard errors pro-
vided a reasonable approximation of the empirical standard deviation and coverage
rates around the nominal rate of 95%.
In a second simulation study, the performance of the proposed method in a setting
with a binary instrumental variable and exposure-dependent censoring was examined.
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Table 4.2: Simulation results comparing proposed IV method to a benchmark
method and naive regression method at different sample sizes under censoring
(∼ 16%)
Benchmark Naive Method Proposed IV Method
Parameter Bias ESD Bias ESD Bias ESD ASE CP
n = 250
γe 0.039 0.208 0.522 0.173 0.028 0.233 0.286 0.982
β1e -0.036 0.563 0.549 0.388 -0.044 0.573 0.603 0.976
β2e 0.027 0.259 0.483 0.183 0.019 0.268 0.264 0.942
n = 500
γe 0.016 0.149 0.497 0.126 0.015 0.168 0.179 0.966
β1e -0.044 0.384 0.552 0.26 -0.044 0.389 0.399 0.956
β2e 0.003 0.173 0.467 0.121 0.002 0.179 0.178 0.946
n = 1000
γe 0.017 0.104 0.497 0.087 0.014 0.115 0.122 0.962
β1e -0.033 0.26 0.575 0.174 -0.035 0.261 0.272 0.964
β2e -0.003 0.126 0.459 0.085 -0.006 0.129 0.124 0.944
Bias, Empirical Bias of Estimates; ESD, sample standard deviation; ASE, mean of esti-
mated standard error via resampling method; CP, empirical coverage probability of 95%
interval
The exogenous covariate Xo and the residual error terms reflecting the influence of an
unmeasured confounder on the exposure-outcome relationship were generated in the
same manner as in the first simulation study. However, the instrumental variable, XI
was generated from a Bern(0.6) distribution and the exposure was generated from the
linear model: Xe = XI +ν. The parameter values of models (4.3) and (4.4) were fixed
at {γ0, γo, γe} = {−0.5, 0.5, 0.5}, {β1o, β1e} = {0.5, 0.5}, {β2o, β2e} = {0.5, 0.5} and
η1(t) = η2(t) = 0.8t+ 1t
2. The censoring time was dependent on the value of the ex-
posure and was generated as: Unif(0.4, 1.2)×I(Xe > 0)+Unif(0.8, 1.2)×I(Xe < 0).
Table 4.2 displays results of the second simulation study at sample sizes n = 250, 500
and 1000. As was the case with independent censoring, the naive method seemed to
produce highly biased estimates, while the proposed IV method seemed to do nearly
as well as the method using the true value of the unmeasured confounder. The per-
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turbation resampling method seemed to estimate the standard error of the parameter
estimates well, with the corresponding 95% confidence intervals producing a coverage
rate ranging from 94% - 98% in all sample sizes. All results discussed in this section
are based on 500 Monte Carlo simulations.
4.5 Application
We applied our method to compare HD and PD modalities for end stage renal
disease (ESRD) patients using data from the United States Renal Data System (US-
RDS). Specifically, we sought to differentiate the two modalities with respect to two
competing risks: (i) death from cardiovascular diseases (CVD) and (ii) death from
other causes. While very few studies have studied the association between cardio-
vascular mortality and dialysis modality, many previous studies have compared HD
and PD modalities with respect to all cause mortality. However, these studies have
yielded conflicting results providing no conclusive evidence for or against the use of
PD. This suggests that an IV analysis might be in order to adequately address un-
measured treatment-outcome confounding and shed some valuable, new insight on
the comparison between modalities, especially for a cause-specific comparison.
We conducted an IV analysis to examine the association between dialysis modality
and the risk of death from cardiovascular diseases and other causes at 5 years since
ESRD incidence. Our study population consisted of incident dialysis patients initi-
ating dialysis between 01/01/2009 and 12/31/2009 and belonging to ESRD Network
11. This network serves dialysis patients in the midwestern states of Michigan, Min-
nesota, North Dakota, South Dakota and Wisconsin. The instrument in our analysis
was the dialysis facility-level variation in PD usage, defined as the facility-specific
proportion of patients initiating dialysis with PD. Given the nature of our analysis
we excluded small dialysis facilities defined as having < 10 PD patients and < 50
patients in total. After this step, our study cohort had 2,001 patients distributed
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across 59 dialysis facilities. To avoid introducing patient-level confounding between
the instrument and unmeasured confounders, historical data from 2006-08 was used
to determine PD usage. The mean PD usage rate within facility varied from 3.5% to
33.9% with a mean of 12.1% and median of 10.2%. The correlation between facility-
level mean PD usage in 2006-08 and 2009-14 was 0.57, and the mean PD usage within
facility was significantly associated (β = 0.531, p < 0.0001) with individual PD usage
in a model adjusting for available patient-level covariates, suggesting potential for a
good instrument.
Table 4.3 presents a comparison of patients initiating dialysis on PD and HD with
respect to age, comorbidities and primary renal diagnosis. On average, PD patients
were younger by about 5 years and healthier in terms of having a lower prevalence of
comorbidities than HD patients. While these observed patient-level factors can be ad-
justed for in a regression analysis, it is plausible that other unmeasured patient-level
confounders might influence both the choice of dialysis modality and survival, thus,
necessitating an IV analysis. Further, given that almost every available risk factor in
Table 4.3 is more prevalent for HD than PD patient, unmeasured confounding seems
likely.
Based on historical evidence as important predictors, we adjusted for the fol-
lowing patient-level risk-factors: age at dialysis initiation, gender, race, ethnicity
(Hispanic or not), primary renal diagnosis (glomerulonephritis (GN) diabetes, hyper-
tension, and others), and binary comorbidity indicators for the presence of cancer, dia-
betes, athlero-sclerotic heart disease (ASHD), congestive heart failure (CHF), chronic
obstructive pulmonary disease (COPD), cerebrovascular accident (CVA), peripheral
vascular disease (PVD), elicit drug use, tobacco use, and alcohol consumption. The
censoring distribution was estimated using a Cox hazards regression model including
all the aforementioned patient-level covariates and the treatment.
In Table 4.4 we present the results from the IV analysis and the corresponding
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Table 4.3: Analysis of USRDS Data: Description of Study Cohort by Dialysis Modal-
ity
Covariate Haemodialysis
Peritoneal
Dialysis
Standardized
Difference
Died 69 % 50 % -29 %
CVD death 22.4 % 21.2 % -2.0 %
Non-CVD death 69.1 % 49.5 % -28.7 %
Age (Years) 64.2 59.3 -0.229
Primary Renal Diagnosis
Diabetes 41.2 42.4 1.8
Hypertension 26.8 27.8 1.5
Glomerulonephritis 8.4 14.1 12.8
Other 23.6 15.6 -14.1
Comorbidities
Alcohol Use 2.8 2.5 -1.1
ASHD 26.1 19.7 -10.7
Cancer 11.6 9.1 -5.8
CHF 37.4 19.7 -28.2
COPD 11.8 7.1 -11.4
CVA 9.5 9.1 -1.1
Diabetes 11.9 9.1 -6.5
Drug Use 1.4 1.0 -2.4
PVD 15.6 9.1 -14.0
Tobacco Use 7.9 10.1 5.4
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Table 4.4: Analysis of USRDS Data: Results from IV and Naive analysis
Parameter IV Analysis Naive Analysis
Parameter Estimate 95% Interval Estimate 95% Interval
γe 1.507 (0.035 , 2.979) 0.458 (0.131 , 0.785)
β1e 0.102 (-0.473 , 0.678) -0.055 (-0.097 , -0.014)
β2e 0.190 (-0.409 , 0.788) -0.046 (-0.088, -0.005)
‘naive’ analysis for each of the proposed inverse-weighting based estimators. For the
‘naive’ analysis, we ignored the presence of unmeasured confounders of the treatment-
outcome relationship and proceeded as we did for the naive analysis in the Simulation
studies. The naive analysis showed the use of PD to be associated with a statistically
significant increase in the marginal risk of death from CVD. This result was con-
firmed in the IV analysis. The cumulative incidence curves for CVD mortality and
non-CVD mortality for a subject with average covariate values, from the naive and
IV analysis, are presented in Figure 4.1 and Figure 4.2 respectively. Also plotted in
these figures are the non-parametric estimate of the CIF obtained using the Aalen-
Johansen estimator. The non-parametric estimate is not adjusted for unobserved and
observed confounders. In terms of non-CVD mortality, both the IV and naive analysis
indicated a significant survival benefit for PD patients at 4.5 years.
Our findings seem to support findings of Johnson et al. (2009) and Kim et al.
(2015), who noted a significantly increased risk of death from CVD and CVD events
for PD patients. Both these studies were registry analyses of a patient population
from a country other than the United States. Further, while they adjusted for a rich
set of observed covariates, neither study addressed unmeasured confounding.
4.6 Discussion
In this chapter we develop an instrumental variable analysis method for addressing
unmeasured confounding in the competing risks setting. Our method can be used for
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binary or continuous exposures, and unlike previously developed methods for com-
peting risks data (Zheng et al. (2017), Richardson et al. (2016)), can accommodate
exposure-dependent censoring. The main strength of the developed method, however,
lies in its ability to estimate the effect of an exposure of interest on the absolute risk
of all causes, simultaneously. We use a semiparametric mixture component model
that guarantees that
∑K
k=1 Fk(∞) = 1. In this regard, our method permits an in-
vestigator to take into account all causes or event types. Prominent methodologies
centered on direct modeling of the CIFs force investigators to focus on a single cause
of interest. When these methodologies are extended to perform IV analysis in the
competing risks setting, as done in Zheng et al. (2017), important features of the
exposure-outcome relationship and the interplay between causes tend to get over-
looked. Thus, the method developed in this chapter provides a unique approach to
adjusting for unmeasured confounding in the competing risks setting and by simulta-
neously modeling exposure effects on all causes, provides a deeper understanding of
the exposure-outcome relationship.
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APPENDIX A
Appendix for Chapter I
In this Appendix we present an expanded version of simulation results presented
in Table 3 of Chapter II, a tabulation of the results mentioned in Section 2.5 and
a scatter plot of the estimated center-specific random effects and ECIs of the two
outcomes - transplantation and death - for the data analysis detailed in Section 2.5.
Table 1 in this document compares the proposed method to a method ignoring the
correlation between cause-specific random effects within a center with respect to Bias,
Empirical Standard Deviation, Asymptotic Standard Error and Coverage Probability
of center effect estimates.
Table 2 in this document compares the proposed method to a method that ig-
nores the correlation between the cause-specific center effects with respect to outlier
classification.
Figure 1 contains two scatterplots. Above is a scatterplot of the center-specific
random effects for cause 1 (Transplantation) and cause 2 (Death). Below is a scat-
terplot of the ECI for cause 1 (Transplantation) and ECI for cause 2 (Death).
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Table A.1: Estimating Center-Specific Effects: Results from 500 Simulated Datasets
Proposed Method
Ignornig Random Effects
Correlation
nj′
True
Value Bias ESD ASE CP Bias ESD ASE CP
20 γj′1 0.0 -0.022 0.234 0.324 0.985 -0.027 0.246 0.337 0.995
γj′2 0.0 -0.013 0.243 0.306 0.975 -0.018 0.253 0.315 0.975
γj′1 0.5 -0.175 0.241 0.298 0.965 -0.217 0.249 0.310 0.965
γj′2 -0.5 0.172 0.249 0.328 0.975 0.227 0.250 0.337 0.940
γj′1 1.0 -0.276 0.243 0.277 0.880 -0.326 0.249 0.285 0.825
γj′2 -1.0 0.403 0.243 0.355 0.835 0.566 0.233 0.363 0.680
40 γj′1 0.0 -0.011 0.226 0.264 0.985 -0.016 0.237 0.273 0.990
γj′2 0.0 -0.008 0.208 0.243 0.985 -0.012 0.213 0.250 0.980
γj′1 0.5 -0.098 0.214 0.233 0.940 -0.129 0.222 0.240 0.925
γj′2 -0.5 0.112 0.217 0.271 0.970 0.155 0.227 0.278 0.935
γj′1 1.0 -0.139 0.204 0.208 0.910 -0.177 0.210 0.214 0.890
γj′2 -1.0 0.265 0.220 0.307 0.920 0.406 0.226 0.313 0.780
60 γj′1 0.0 -0.003 0.197 0.231 0.970 -0.008 0.205 0.237 0.965
γj′2 0.0 -0.006 0.188 0.210 0.975 -0.009 0.193 0.214 0.980
γj′1 0.5 -0.057 0.196 0.199 0.965 -0.084 0.199 0.204 0.965
γj′2 -0.5 0.065 0.213 0.241 0.960 0.100 0.214 0.245 0.935
γj′1 1.0 -0.091 0.169 0.178 0.955 -0.122 0.172 0.181 0.920
γj′2 -1.0 0.218 0.217 0.276 0.880 0.333 0.219 0.281 0.800
80 γj′1 0.0 -0.015 0.175 0.209 0.995 -0.024 0.183 0.215 0.995
γj′2 0.0 -0.022 0.178 0.191 0.970 -0.028 0.185 0.194 0.965
γj′1 0.5 -0.071 0.177 0.180 0.960 -0.095 0.183 0.184 0.950
γj′2 -0.5 0.065 0.181 0.218 0.970 0.089 0.186 0.222 0.965
γj′1 1.0 -0.107 0.160 0.161 0.895 -0.134 0.164 0.163 0.855
γj′2 -1.0 0.195 0.198 0.255 0.920 0.283 0.202 0.259 0.810
100 γj′1 0.0 -0.026 0.164 0.195 0.990 -0.036 0.171 0.199 0.985
γj′2 0.0 -0.018 0.154 0.176 0.980 -0.025 0.159 0.179 0.970
γj′1 0.5 -0.081 0.147 0.167 0.965 -0.103 0.150 0.170 0.945
γj′2 -0.5 0.058 0.200 0.203 0.925 0.077 0.207 0.206 0.915
γj′1 1.0 -0.099 0.137 0.149 0.930 -0.124 0.141 0.151 0.885
γj′2 -1.0 0.157 0.191 0.241 0.945 0.232 0.196 0.245 0.890
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Table A.2: Analysis of Scientific Registry of Transplant Recipients (SRTR) Data:
Comparing Classification of Organ Procurement Organizations (OPOs) based on Ex-
cess Cumulative Incidence (ECI) of Death and Kidney Transplantation
Classification of
OPOs Ignornig
Correlation of
Random Effects
Classification of OPOs Using Proposed Method
Based on ECI of Transplant Based on ECI of Death
Low
Outlier
Not an
Outlier
High
Outlier
Low
Outlier
Not an
Outlier
High
Outlier
Low Outlier 17 1 0 16 1 0
Not an Outlier 0 24 2 5 23 1
High Outlier 0 1 13 0 0 12
92
Figure A.1: Scatter Plots of center-specific random effects (above) and Excess Cause-
specific Cumuluative Incidence (below) for the outcomes of Transplant and Death for
58 OPOs
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APPENDIX B
Appendix for Chapter III
In this Appendix we present a sketch of the proof of THEOREM 1 and THEO-
REM 2 in Chapter 4.
Proof of THEOREM 1
To establish the asymptotic properties of the estimator proposed in the section
2.4, we first assume the following regularity conditions for i = 1, ...., n:
a. {T˜i,∆i,Xi, Ai}are independent and identically distributed
b. Xi is bounded almost surely
c. Λz(τ) <∞, where τ is some pre-specified time-point
d. Pr(Zi = z|Xi) > 0 for z = {0, 1}
e. Positive definiteness of the matrix Ω(β0) = E[X
⊗2
i pi(β0)(1 − pi(β0))], where
pi(β0) = Pr(Zi = 1|Xi)
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With respect to censoring, we assume that the censoring time for subjects assigned
to IV level Z = z follows a proportional hazards model λciz = λ0z(t) exp(X
T
i θ0z).
Then, an estimate for wci (t) when randomly assigned to IV level Z = z is given
by wˆci (t; θˆz) = exp(Λˆ0z(t; θˆz) exp(X
T
i θˆz)). Here, we assume that Λˆ0z(t; θˆz) is the
Breslow-Aalen estimator for Λ0z(t), so that:
Λˆ0z(t; θˆz) =
1
n
n∑
i=1
t∫
0
dN ci (s)
B
(0)
c (s; θˆ)
, (B.1)
whereB
(d)
c (s; θˆ) = n−1
∑n
i=1 Yi(s)X
⊗d
i exp{(XTi θˆz)} for d = 0, 1, 2 with a⊗0 = 1, a⊗1 =
a, a⊗2 = aaT for a vector a. Further, θ0z is assumed to be estimated through partial
likelihood by θˆz, the solution of the score equation, Uc(θ) = 0, where:
Uc(θ) =
n∑
i=1
τ∫
0
Xi − X¯c(t,θ)dN ci (t), (B.2)
X¯c(t,θ) =
B
(1)
c (s; θ)
B
(0)
c (s; θ)
. (B.3)
With these assumptions on the censoring model, to accomodate covariate-dependent
censoring, we assume the following additional regularity conditions:
f. Continuity of the following functions:
b
(1)
c (s;θ) = ∂∂θb
(0)
c (s;θ), b
(2)
c (s;θ) = ∂∂θ∂θT b
(0)
c (s;θ),
where b
(d)
c (s;θ) is the limiting value of B
(d)
c (s;θ) ford = 0, 1, 2 with b
(0)
c (s;θ)
and b
(1)
c (s;θ) bounded and b
(2)
c (s;θ) bounded away from 0 for t ∈ [0, τ ] and θ
in an open set
g. Positive definiteness of the matrix Ωc(θ) =
∫ τ
0
vc(t,θ)bc(t,θ)dΛ
c
0(t), where
vc(t,θ) = b
(2)
c (t,θ)/b
(0)
c (t,θ) − x¯c(t,θ) and x¯c(t,θ) = b(1)c (s; θ)/b(0)c (s; θ) is the
limiting value of X¯c(t,θ)
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As noted in the paper, under assumed regularity conditions a. - g., the consistency
of Λˆz is easily proved through the consistency of βˆ and θˆ, the continuous mapping
theorem, and the Uniform Strong Law of Large Numbers (USLLN). With respect to
asymptotic normality, we begin with the decomposition:
n1/2(Λˆz(t)− Λz(t)) = αˆz1(t) + αˆz2(t) + αˆz3(t) + αˆz4(t)
where
αˆz1(t) = n
1/2{Λˆz(t; βˆ, θˆz, Λˆc0z)− Λz(t;β0, θˆz, Λˆc0z)}
αˆz2(t) = n
1/2{Λˆz(t;β0, θˆz, Λˆc0z)− Λz(t;β0,θ0z, Λˆc0z)}
αˆz3(t) = n
1/2{Λˆz(t;β0,θ0z, Λˆc0z)− Λz(t;β0,θ0z,Λc0z)}
αˆz4(t) = n
1/2{Λˆz(t;β0,θ0z,Λc0z)− Λz(t)}
for z ∈ {0, 1}, with Λˆz(t) = Λˆz(t; βˆ, θˆ, Λˆc0z) and
Λˆz(t;β0, θˆz, Λˆ
c
0z) =
1
n
n∑
i=1
t∫
0
wˆci (s; θˆz)w
e
i (β0)dNiz(s)
n−1
∑n
l=1 wˆ
c
l (s; θˆz)w
e
l (β0)Ylz(s)
wˆci (s; θˆz) = exp(Λˆ0z(s; θˆz) exp(X
T
i θˆz))
Λˆz(s;β0,θ0z, Λˆ
c
0z) =
1
n
n∑
i=1
t∫
0
wˆci (s;θ0z)w
e
i (β0)dNiz(s)
n−1
∑n
l=1 wˆ
c
l (t;θ0z)w
e
l (β0)Ylz(s)
wˆci (s;θ0z) = exp(Λˆ
c
0z(s;θ0z) exp(X
T
i θ0z))
Λˆz(t;β0,θ0z,Λ
c
0z) =
1
n
n∑
i=1
t∫
0
wci (s;θ0z)w
e
i (β0)dNiz(s)
n−1
∑n
l=1 w
c
l (s;θ0z)w
e
l (β0)Ylz(s)
wci (s;θ0z) = exp(Λ
c
0z(s) exp(X
T
i θ0z))
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We can express αˆz1(t) as follows:
αˆz1(t) = n
−1/2
n∑
i=1
t∫
0
{
wei (βˆ)
B(s; βˆ, θˆz)
− w
e
i (β0)
B(s;β0, θˆz)
}
wˆci (s; θˆz)dNiz(s), (B.4)
where B(s;β0, θˆz) = n
−1∑n
i=1 wˆ
c
i (s; θˆz)w
e
i (β0)Yiz(s), so that αˆz1(t) = αˆz11(t) +
αˆz12(t), where:
αˆz11(t) = n
−1/2
n∑
i=1
t∫
0
{
wei (βˆ)− wei (β0)
B(s; βˆ, θˆz)
}
wˆci (s; θˆz)dNiz(s)
αˆz12(t) =
n∑
i=1
t∫
0
wei (β0)
{
1
B(s; βˆ, θˆz)
− 1
B(s;β0, θˆz)
}
wˆci (s; θˆz)dNiz(s).
With respect to αˆz11(t), by a linear Taylor series expansion, we have:
n1/2{wei (βˆ)− wei (β0)} = aTi (β0)(βˆ − β0), (B.5)
where, as defined in the paper, aTi (β0) =
∂wei (β)
∂β
∣∣∣
β0
. Further, from maximum likeli-
hood theory:
n1/2{βˆ − β0} = Ω−1(β0)n−1/2
n∑
i=1
ψi(β0) + op(1) (B.6)
Combining the above results, we have:
n1/2{wei (βˆ)− wei (β0)} = aTi (β0)Ω−1(β0)n−1/2
n∑
i=1
ψi(β0) + op(1) (B.7)
Using the above result, then applying SLLN and continuity, as n → ∞, we can
re-express αˆz11(t) as:
αˆz11(t) = h
T
z (t)Ω
−1(β0)n−1/2
n∑
i=1
ψi(β0) + op(1) (B.8)
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hz(t) = E
[ t∫
0
wˆci (s; θˆz)ai(β0)
E[wˆci (s; θˆz)w
e
i (β0)Yiz(s)]
dNiz(s)
]
(B.9)
With respect to αˆz12(t), combining a Taylor expansion with B.3
n1/2{B−1(s; βˆ, θˆz)−B−1(s;β0, θˆz)} = −B
β(s;β0, θˆz)
B(s;β0, θˆz)2
Ω−1(β0)n−1/2
n∑
i=1
ψi(β0)+op(1)
(B.10)
where we define:
Bβ(s;β0, θˆz) =
∂B(s;β, θˆz)
∂β
∣∣∣
β0
=
1
n
n∑
i=1
Yiz(t)w
e
i (β0)wˆ
c
i (s; θˆz)ai(β0), (B.11)
which converges almost surely to bβ(s;β0, θˆz) = E[Yiz(t)w
e
i (β0)wˆ
c
i (s; θˆz)ai(β0)]. Then,
applying SLLN and continuity:
αˆz12(t) = d
T
z (t)Ω
−1(β0)n−1/2
n∑
i=1
ψi(β0) + op(1) (B.12)
dz(t) =
t∫
0
bβ(s;β0, θˆz)
b(s;β0, θˆz)
dNiz(s), (B.13)
where b(s;β0, θˆz) = E[wˆ
c
i (s; θˆz)w
e
i (β0)Yiz(s)] Combining the above results,
αˆz1(t) = {hz(t) + dz(t)}TΩ−1(β0)n−1/2
n∑
i=1
ψi(β0) + op(1). (B.14)
As we did for αˆz1(t), we can write αˆz2(t) = αˆz21(t) + αˆz22(t), where
αˆz21(t) = n
−1/2
n∑
i=1
t∫
0
wei (β0)B(s;β0, θˆz)
−1{wˆci (s; θˆz)− wˆci (s;θ0z)}dNi(s) (B.15)
αˆz22(t) =
n∑
i=1
t∫
0
wei (β0)
{
1
B(s;β0, θˆz)
− 1
B(s;β0,θ0z)
}
wˆci (s;θ0z)dNiz(s). (B.16)
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Through standard partial likelihood theory (Fleming and Harrington, 1991),
n1/2(θˆz − θ0z) = Ω−1c (θ0z)n−1/2
n∑
i=1
ψci (θ0z) + op(1) (B.17)
Ωc(θ) =
τ∫
0
vc(t,θ)bc(t,θ)dΛ
c
0(t), (B.18)
ψci (θ) =
τ∫
0
{Xi − x¯c(t,θ)}dM ci (t). (B.19)
Using a Taylor expansion, the SLLN and continuity,
n1/2{wˆci (s; θˆ)− wˆci (s;θ0z)} = wˆci (s;θ0z)kTi (s,θ0z)Ω−1c (θ0z)n−1/2
n∑
i=1
ψci (θ0z) + op(1)
(B.20)
kTi (s,θ0z) =
s∫
0
exp{XTi θ0z − x¯c(u,θ0z)}dΛc0z(u). (B.21)
Substituting the above expression into αˆz21(t), then applying SLLN,
αˆz21(t) = g
T
z (t)Ω
−1
c (θ0z)n
−1/2
n∑
i=1
ψci (θ0z) + op(1) (B.22)
gTz (t) = E
[ t∫
0
wei (β0), wˆ
c
i (s;θ0z)bz(s;β0,θ0z)
−1ki(s)dNiz(s)
]
. (B.23)
With respect to αˆz22(t), through another Taylor series expansion,
n1/2{B−1(s;β0, θˆz)−B−1(s;β0,θ0z)} = −B
θ(s;β0,θ0z)
B(s;β0,θ0z)2
Ω−1c (θ0z)n
−1/2
n∑
i=1
ψci (θ0z)+op(1)
(B.24)
where we define:
Bθ(s;β0,θ0z) =
∂B(s;β0,θ)
∂θ
∣∣∣
θ0z
=
1
n
n∑
i=1
Yiz(s)w
e
i (β)wˆ
c
i (s;β,θ0z)ki(s), (B.25)
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which converges almost surely to bθ(s;β0,θ0z) = E[Yiz(s)w
e
i (β0)wˆ
c
i (s;β,θ0z)ki(s)].
Substituting into expression for αˆz22(t), and again applying SLLN and using continu-
ity:
αˆz22(t) = f
T
z (t)Ω
−1
c (θ0z)n
−1/2
n∑
i=1
ψci (θ0z) + op(1) (B.26)
fz(t) =
t∫
0
bθ(s;β0,θ0z)
b(s;β0,θ0z)
dΛz(s). (B.27)
Combining the above results,
αˆz2(t) = {gz(t) + fz(t)}TΩ−1c (θ0z)n−1/2
n∑
i=1
ψci (θ0z) + op(1). (B.28)
With respect to αˆz3(t) we can write:
αˆz3(t) = n
−1/2
n∑
i=1
t∫
0
wei (β0)B(s;β0,θ0)
−1{wˆci (s;θ0z)− wci (s;θ0z)}dNi(s). (B.29)
Applying the Functional Delta Method,
n1/2{wˆci (s;θ0)− wci (s;θ0z)} = wci (s;θ0z)n1/2{Λˆci(s;θ0z)− Λci(s)} (B.30)
= wci (s;θ0z)n
−1/2
n∑
l=1
s∫
0
exp{θT0zXi}
Bc(u,θ0z)
dMCl (u) = op(1). (B.31)
Substituting this expression into the above expression for αˆz3(t), changing the orders
of integration and summation, then applying the SLLN,
αˆz3(t) = n
−1/2
n∑
i=1
t∫
0
qz(s, t)b(s;β0,θ0z)
−1dMCi (s) (B.32)
qz(s, t) = E
[
exp{θ0zTXi}
t∫
u
wei (β0), w
C
i (s;θ0z)b(s;β0,θ0z)
−1dNiz(s)
]
. (B.33)
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Finally, the quantity, αˆz4(t) can be written as
αˆz4(t) = n
−1/2
n∑
i=1
t∫
0
wei (β0), w
C
i (s;θ0z)b(s;β0,θ0z)
−1dMiz(s). (B.34)
Thus, combining the above results,
n1/2{Λˆz(t)− Λ(t)} = n−1/2
n∑
i=1
Φiz(t) + op(1) (B.35)
where Φiz(t) as defined in Theorem 1 is:
Φiz(t) = {hz(t) + dz(t)}TΩ−1(β0)n−1/2
n∑
i=1
ψi(β0)
+{gz(t) + fz(t)}TΩ−1C (θ0z)n−1/2
n∑
i=1
ψCi (θ0z)
+n−1/2
n∑
i=1
t∫
0
qz(s, t)b(s;β0,θ0z)
−1dMCi (s)
+n−1/2
n∑
i=1
t∫
0
wei (β0), w
C
i (s;θ0z)b(s;β0,θ0z)
−1dMiz(s).
As n → ∞, n1/2{Λˆz(t) − Λ(t)} behaves like asume of independent and identically
distributed mean 0 random variates. Therefore, by the multivariate central limit theo-
rem, for any finite set of (say k) time points, the vector n1/2[{Λˆz(t1)−Λ(t1)}, ...., {Λˆz(tk)−
Λ(tk)}] converges to a mean zero multivariate normal distribution. Using techniques
in Bilias, Gu and Ying (1997), n1/2{Λˆz(t)− Λ(t)} can be shown to be tight (Pollard
(1990), van der Vaart and Wellner (1996)); so that n1/2{Λˆz(t) − Λ(t)} converges to
a mean zero Gaussian process with covariance function E{Φiz(s)Φiz(t)} for any pair
of time points (s, t) ∈ [0, τ ]× [0, τ ].
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Proof of THEOREM 2
With respect to asymptotic normality, we begin with the decomposition:
n1/2(δˆ(t)− δ(t)) = γˆ1(t) + γˆ2(t)
where
γˆ1(t) = n
1/2{δˆ(t; µˆA,1, µˆA,0, µˆT,1, µˆT,0)− δˆ(t;µA,1, µA,0, µˆT,1, µˆT,0)}
γˆ2(t) = n
1/2{δˆ(t;µA,1, µA,0, µˆT,1, µˆT,0)− δ(t)}
We can express γˆ1(t) as follows:
γˆ1(t) = n
−1/2
n∑
i=1
[R−1(βˆ)−R−1(β0)]{µˆT,1(t)− µˆT,0(t)} (B.36)
where
R(βˆ) = µA,1(βˆ)− µA,0(βˆ)
R(β0) = µA,1(β0)− µA,0(β0)
µA,z(βˆ) =
∑n
i=1w
e
i (βˆ)AiI(Zi = z)∑n
i=1w
e
i (βˆ)I(Zi = z)
µA,z(β0) =
∑n
i=1w
e
i (β0)AiI(Zi = z)∑n
i=1w
e
i (β0)I(Zi = z)
With respect to the expression for γˆ1(t), by a linear Taylor series expansion:
n1/2{R−1(βˆ)−R−1(β0)} = −R
β(β0)
R(β0)2
(βˆ − β0) + op(1) (B.37)
where, we define:
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Rβ(β0) =
∂R(β)
∂β
∣∣∣
β0
=
∑
z∈{0,1}
[∑n
i=1 I(Zi = z)I(Ai = 1)a
e
i (β0)∑n
i=1 I(Zi = z)w
e
i
−
∑n
i=1 WzI(Zi = z)I(Ai = 1)a
e
i (β0)
(
∑n
i=1 I(Zi = z)w
e
i )
2
]
(B.38)
where Wz =
∑n
i=1 I(Zi=z)I(Ai=1)w
e
i∑n
i=1 I(Zi=z)w
e
i
and from maximum likelihood theory:
n1/2{βˆ − β0} = Ω−1(β0)n−1/2
n∑
i=1
ψi(β0) + op(1) (B.39)
Combining the above results, we have:
n1/2{R−1(βˆ)−R−1(β0)} = −R
β(β0)
R(β0)2
Ω−1(β0)n−1/2
n∑
i=1
ψi(β0) + op(1) (B.40)
Using the above result, and by application of strong law of large numbers and conti-
nuity, as n→∞, we can write γˆ1(t) as:
γˆ1(t) = Q
TΩ−1(β0)n−1/2
n∑
i=1
ψi(β0) + op(1) (B.41)
where Q = E[−Rβ(β0)
R(β0)2
].
We can write γˆ2(t) as:
γˆ2(t) = n
1/2[{µˆT,1(t)− µˆT,0(t)} − {µT,1(t)− µT,0(t)}] 1
µA,1(t)− µA,0(t)
= n1/2
[{ t∫
0
Sˆ1(u)− S1(u)dt
}
−
{ t∫
0
Sˆ0(u)− S0(u)dt
}]
1
µA,1(t)− µA,0(t)
Note that, as Λˆz(t) converges almost surely to Λz(t) (Theorem 1), through continuity,
Sˆz(t) converges almost surely to Sz(t). This implies that
∫ t
0
Sˆz(u)du
a.s−→ ∫ t
0
Sz(u)du,
which in turn implies the almost surely convergence of δˆ(t) to δ(t) in t ∈ [0, τ ]. Fur-
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ther, by functional Delta Method, n1/2(Sˆz(u)−Sz(u)) = −Sz(u)n1/2{Λˆz(u)−Λz(u)}.
By integrating, we get that n1/2{∫ t
0
Sˆz(u)−Sz(u)dt} = −n1/2
∫ t
0
Sz(u){Λˆz(u)−Λz(u)}.
Switching the order of integration, and substituting µT,z(t) =
∫ t
0
Sz(u)dt, we obtain:
n1/2{µˆT,z(t)− µT,z(t)} = −n1/2
t∫
0
{µT,z(t)− µT,z(u)}d{Λˆz(u)− Λz(u)} (B.42)
Using results from Theorem 1, this can be written as:
n1/2{µˆT,z(t)− µT,z(t)} = −n−1/2
n∑
i=1
t∫
0
{µT,z(t)− µT,z(u)}dΦiz(u) + op(1), (B.43)
such that, asymptotically,
γˆ2(t) = {µA,1(t)− µA,0(t)}−1n−1/2
n∑
i=1
Σi(t);
Σi(t) =
t∫
0
{µT,0(t)− µT,0(u)}dΦi0(u)−
t∫
0
{µT,1(t)− µT,1(u)}dΦi1(u)
Thus, combining the above results,
n1/2(δˆ(t)− δ(t)) = n−1/2
n∑
i=1
ξi(t) + op(1)
where, ξi(t), as defined in Theorem 2 is given by:
ξi(t) = Q
TΩ−1(β0)
n∑
i=1
ψi(β0) + {µA,1(t)− µA,0(t)}−1
n∑
i=1
Σi(t)
Following results from Theorem 1, n1/2(δˆ(t)−δ(t)) behaves like a sum of independent
and identically distributed mean 0 random variates. Hence, by multivariate central
limit theorem n1/2[{δˆ(t1)− δ(t1)}, ..., {δˆ(tk)− δ(tk)}]. Further, using arguments anal-
ogous to those used in the proof of Theorem 1, n1/2(δˆ(t) − δ(t)) converges to with
104
covariance function E{ξi(s)ξi(t)} for any pair of time points (s, t) ∈ [0, τ ]× [0, τ ].
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